Wednesday, 03 August 2011 04:47

Glycerols and Glycols

Uses

Glycols and glycerols have numerous applications in industry because they are completely water-soluble organic solvents. Many of these compounds are used as solvents for dyes, paints, resins, inks, insecticides and pharmaceuticals. In addition, their two chemically reactive hydroxyl groups make the glycols important chemical intermediates. Among the many uses of glycols and polyglycols, major ones include being an additive for freezing-point depression, for lubrication and for solubilization. The glycols also serve as indirect and direct additives to foods and as ingredients in explosive and alkyd resin formulations, theatrical fogs and cosmetics.

Propylene glycol is used widely in pharmaceuticals, cosmetics, as a humectant in certain foods and as a lubricant. It is also used as a heat-transfer fluid in uses where leakage might lead to food contact, such as in coolants for dairy refrigeration equipment. It is also used as a solvent in food colours and flavours, an antifreeze in breweries and establishments, and an additive to latex paint to provide freeze-thaw stability. Propylene glycol, ethylene glycol and 1,3-butanediol are components of aircraft de-icing fluids. Tripropylene glycol and 2,3-butanediol are solvents for dye-stuffs. The butanediols (butylene glycols) are used in the production of polyester resins.

Ethylene glycol is an antifreeze in cooling and heating systems, a solvent in the paint and plastics industries, and an ingredient of de-icing fluid used for airport runways. It is used in hydraulic brake fluids, low-freezing dynamite, wood stains, adhesives, leather dyeing, and tobacco. It is also serves as a dehydrating agent for natural gas, a solvent for inks and pesticides, and an ingredient in electrolytic condensers. Diethylene glycol is a humectant for tobacco, casein, synthetic sponges, and paper products. It is also found in cork compositions, book-binding adhesives, brake fluids, lacquers, cosmetics and antifreeze solutions for sprinkler systems. Diethylene glycol is used for water seals for gas tanks, as a lubricating and finishing agent for textiles, a solvent for vat dyes, and a natural-gas dehydrating agent. Triethylene glycol is a solvent and lubricant in textile dyeing and printing. It is also used in air disinfection and in various plastics to increase pliability. Triethylene glycol is a humectant in the tobacco industry and an intermediate for the manufacture of plasticizers, resins, emulsifiers, lubricants and explosives.

Some measure of the versatility of glycerol can be gained from the fact that some 1,700 uses for the compound and its derivatives have been claimed. Glycerol is used in food, pharmaceuticals, toiletries and cosmetics. It is a solvent and a humectant in such products as tobacco, confectionery icing, skin creams and toothpaste, which would otherwise deteriorate on storage by drying out. In addition, glycerol is a lubricant added to chewing gum as a processing aid; a plasticizing agent for moist, shredded coconut; and an additive for maintaining the smoothness and moisture in drugs. It serves to keep frost from windshields and is an antifreeze in automobiles, gas meters and hydraulic jacks. The largest single use of glycerol, however, is in the production of alkyd resins for surface coatings. These are prepared by condensing glycerol with a dicarboxylic acid or anhydride (usually phthalic anhydride) and fatty acids. A further major use of glycerol is in the production of explosives, including nitroglycerine and dynamite.

Glycerol

Glycerol is a trihydric alcohol and undergoes reactions characteristic of alcohols. The hydroxyl groups have varying degrees of reactivity, and those in the 1- and 3- positions are more reactive than that in the 2- position. By using these differences in reactivity and by varying the proportions of reactants, it is possible to make mono-, di- or tri- derivatives. Glycerol is prepared either by the hydrolysis of fats, or synthetically from propylene. The chief constituents of virtually all animal and vegetable oils and fats are triglycerides of fatty acids.

Hydrolysis of such glycerides yields free fatty acids and glycerol. Two hydrolysis techniques are used—alkaline hydrolysis (saponification) and neutral hydrolysis (splitting). In saponification, fat is boiled with sodium hydroxide and sodium chloride, resulting in the formation of glycerol and the sodium salts of fatty acids (soaps).

In neutral hydrolysis, the fats are hydrolyzed by a batch or semi-continuous process in a high-pressure autoclave, or by a continuous countercurrent technique in a high-pressure column. There are two main processes for the synthesis of glycerol from propylene. In one process, propylene is treated with chlorine to give allyl chloride; this reacts with sodium hypochlorite solution to give glycerol dichlorohydrin, from which glycerol is obtained by alkaline hydrolysis. In the other process, propylene is oxidized to acrolein, which is reduced to allyl alcohol. This compound may be hydroxylated with aqueous hydrogen peroxide to give glycerol directly, or treated with sodium hypochlorite to give glycerol monochlorohydrin, which, upon alkaline hydrolysis, yields glycerol.

Hazards

Glycerol has a very low toxicity (oral LD50 (mouse) 31.5 g/kg) and is generally considered harmless under all normal conditions of use. Glycerin produces only very slight diuresis in healthy individuals receiving a single oral dose of 1.5 g/kg or less. Adverse effects following oral administration of glycerin include mild headache, dizziness, nausea, vomiting, thirst and diarrhoea.

When present as a mist, it is classified by the American Conference of Governmental Industrial Hygienists (ACGIH) as a “particulate nuisance”, and as such a TLV of 10 mg/m3 has been assigned. In addition, the reactivity of glycerol makes it dangerous, and liable to explode in contact with strong oxidizing agents such as potassium permanganate, potassium chlorate and so on. Consequently it should not be stored near such materials.

Glycols and derivatives

The commercially important glycols are aliphatic compounds possessing two hydroxyl groups, and are colourless, viscous liquids that are essentially odourless. Ethylene glycol and diethylene glycol are of major importance among the glycols and their derivatives. The toxicity and hazard of certain important compounds and groups are discussed in the final section of this article. None of the glycols or their derivatives that have been studied have been found to be mutagenic, carcinogenic or teratogenic.

The glycols and their derivatives are combustible liquids. since their flashpoints are above normal room temperature, the vapours are liable to be present in concentrations within the flammable or explosive range only when heated (e.g., ovens). For this reason they present no more than a moderate fire risk.

Synthesis. Ethylene glycol is produced commercially by the air oxidation of ethylene, followed by hydration of the resulting ethylene oxide. Diethylene glycol is produced as a by-product of the production of ethylene glycol. Similarly, propylene glycol and 1,2-butanediol are produced by the hydration of propylene oxide and butylene oxide, respectively. 2,3-Butanediol is produced by the hydration of 2,3-epoxybutane; 1,3-butanediol is produced by the catalytic hydrogenation of aldol using Raney nickel; and 1,4-butanediol is produced by the reaction of acetylene with formaldehyde, followed by hydrogenation of the resulting 2-butyne-1,4-diol.

Hazards of Common Glycols

Ethylene glycol. The oral toxicity of ethylene glycol in animals is quite low. However, from clinical experience it has been estimated that the lethal dose for an adult human is about 100 cm3 or about 1.6 g/kg, thus indicating a greater toxic potency for humans than for laboratory animals. The toxicity is due to the metabolites, which vary for different species. Typical effects of excessive oral intake of ethylene glycol are narcosis, depression of the respiratory centre, and progressive kidney damage.

Monkeys have been maintained for 3 years on diets containing 0.2 to 0.5% of ethylene glycol without apparent adverse effects; no tumours were found in the bladder, but there were oxalate crystals and stones. Primary eye and skin irritation are generally mild in response to ethylene glycol, but the material can be absorbed through the skin in toxic amounts. Exposure of rats and mice for 8 hours/day for 16 weeks to concentrations ranging from 0.35 to 3.49 mg/l failed to induce organic injury. At the higher concentrations, mist and droplets were present. Consequently, repeated exposures of humans to vapours at room temperature should not present a significant hazard. Ethylene glycol does not seem to present a significant hazard from the inhalation of vapours at room temperatures or from skin or oral contact under reasonable industrial conditions. However, an industrial inhalation hazard could be generated if ethylene glycol were heated or vigorously agitated (generating a mist), or if appreciable skin contact or ingestion occurred over an extended period of time. The primary health hazard of ethylene glycol is related to the ingestion of large quantities.

Diethylene glycol. Diethylene glycol is quite similar to ethylene glycol in toxicity, although without production of oxalic acid. It is more directly toxic to the kidneys than ethylene glycol. When excessive doses are ingested, the typical effects to be expected are diuresis, thirst, loss of appetite, narcosis, hypothermia, kidney failure and death, depending on the severity of exposure. Mice and rats exposed to diethylene glycol at levels of 5 mg/m3 for 3 to 7 months experienced changes in central nervous and endocrine systems and internal organs, and other pathological changes. While not of practical concern, when fed at high doses to animals, diethylene glycol has produced bladder stones and tumours, probably secondary to the stones. These may have been due to monoethylene glycol present in the sample. As with ethylene glycol, diethylene glycol does not seem to present a significant hazard from the inhalation of vapours at room temperatures or from skin or oral contact under reasonable industrial conditions.

Propylene glycol. Propylene glycol presents a low toxicity hazard. It is hygroscopic, and in a study of 866 human subjects, was found to be a primary irritant in some people, probably due to dehydration. It might also cause allergic skin reactions in over 2% of people with eczema. Long-term exposures of animals to atmospheres saturated with propylene glycol are without measurable effect. As a result of its low toxicity, propylene glycol is used widely in pharmaceutical formulations, cosmetics and, with certain limitations, in food products.

Dipropylene glycol is of very low toxicity. It is essentially non-irritating to the skin and eyes and, because of its low vapour pressure and toxicity, is not an inhalation problem unless large quantities are heated in a confined space.

Butanediols. Four isomers exist; all are soluble in water, ethyl alcohol and ether. They have low volatility so inhalation is not a concern under normal industrial conditions. With the exception of the 1,4- isomer, the butanediols create no significant industrial hazard.

In rats, massive oral exposures of 1,2-butanediol induced deep narcosis and irritation of the digestive system. Congestive necrosis of the kidney may also occur. Delayed deaths are believed to be the result of progressive renal failure, while acute fatalities are probably attributable to narcosis. Eye contact with 1,2-butanediol may result in corneal injury, but even prolonged skin contact is usually innocuous with respect to primary irritation and absorption toxicity. No adverse effects of vapour inhalation have been reported.

1,3-Butanediol is essentially non-toxic except in overwhelming oral doses, in which case narcosis may occur.

Little is known abut the toxicity of 2,3-butanediol, but from the few animal studies published, it appears to lie between 1,2- and 1,3-butanediols in toxicity.

1,4-Butanediol is about eight times as toxic as the 1,2-isomer in acute toxicity tests. Acute ingestion results in severe narcosis and possibly renal injury. Death probably results from collapse of the sympathetic and parasympathetic nervous systems. It is not a primary irritant, nor is it easily absorbed percutaneously.

Glycols and glycerols tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 04:43

Glycol Ethers

Uses

Glycol ethers are used extensively as solvents because they tend to be quite soluble in both water and organic liquids. General uses include inks and dyes, enamels, paints and as cleaning agents in the dry-cleaning and glass-cleaning industries. The semiconductor industry also uses these compounds extensively as solvents and cleaning agents.

The ethylene glycol ethers are used widely as solvents for resins, lacquers, paints, varnishes, dyes and inks, as well as components of painting pastes, cleaning compounds, liquid soaps, cosmetics and hydraulic fluids. Propylene and butylene glycol ethers are valuable as dispersing agents and as solvents for lacquers, paints, resins, dyes, oils and greases.

Ethylene glycol monoethyl ether is a solvent in the lacquer, printing, metal and chemical industries. It is also used for dyeing and printing in the textile industry and as a leather-finishing agent, an anti-icing additive for aviation fuels, and a component of varnish removers and cleansing solutions. Diethylene glycol monomethyl ether and ethylene glycol monobutyl ether acetate function in industry as high-boiling solvents. Diethylene glycol monomethyl ether is used for non-grain-raising wood stains, for brushing lacquers with mild odours, for stamp pad inks and for leather finishing. In the paint industry, it is a coalescing agent for latex paint; and in the textile industry, it is used for printing, textile soaps and dye pastes, as well as for setting the twist and conditioning yarns and cloth.

The solvents diethylene glycol monomethyl ether, diethylene glycol monoethyl ether and diethylene glycol mono-n-butyl ether serve as diluents in hydraulic brake fluids. 2-Phenoxyethanol is a fixative for perfumes, cosmetics and soaps, a textile dye carrier and a solvent for cleaners, inks, germicides and pharmaceuticals. 2-Methoxyethanol is also a perfume fixative. It is used in the manufacture of photographic film, as a jet fuel anti-icing additive, as a solvent for resins used in the electronics industry, and as a leather-dyeing agent. 2-Methoxyethanol and propylene glycol methyl ether are useful for solvent-sealing of cellophane. Ethylene glycol mono-n-butyl ether is a solvent for protective coatings and for metal cleaners. It is used in the textile industry to prevent spotting in printing or dyeing.

Hazards

Generally speaking, the acute effects of glycol ethers are limited to the central nervous system and are similar to acute solvent toxicity. These effects include dizziness, headache, confusion, fatigue, disorientation, slurred speech and (if severe enough) respiratory depression and loss of consciousness. The effects of long-term exposure include skin irritation, anaemia and bone marrow supression, encephalopathy and reproductive toxicity. 2-Methoxyethanol and 2-ethoxyethanol (and their acetates) are most toxic. Because of their relatively low volatility, exposure most often occurs as a result of skin contact with liquids, or inhalation of vapours in closed spaces.

Most of the ethylene glycol ethers are more volatile than the parent compound and, consequently, less easily controlled with respect to vapour exposure. All of the ethers are more toxic than ethylene glycol and exhibit a similar symptomatological complex.

Ethylene glycol monomethyl ether (methyl cellosolve; Dowanol EM; 2-methoxyethanol). The oral LD50 for ethylene glycol monomethyl ether in rats is associated with delayed deaths involving lung oedema, slight liver injury, and extensive kidney damage. Renal failure is the probable cause of death in response to repeated oral exposures. This glycol ether is moderately irritating to the eye, producing acute pain, inflammation of the membranes, and corneal clouding which persists for several hours. Although ethylene glycol monomethyl ether is not appreciably irritating to skin, it can be absorbed in toxic amounts. Experience with human exposure to ethylene glycol monomethyl ether has indicated that it can result in the appearance of immature leucocytes, monocytic anaemia, and neurological and behavioural changes. Studies have also shown that inhalation exposure in humans can lead to forgetfullness, personality changes, weakness, lethargy and headaches. In animals, inhalation of higher concentrations can result in testicular degeneration, damage to the spleen, and blood in the urine. Animal studies have shown anaemia, thymus and marrow damage at 300 ppm. At 50 ppm during pregnancy in animals, major foetal abnormalities were reported. The most important health effect seems to be the effect on the human reproductive system, with diminished spermatogenesis. Thus, it is evident that the monomethyl ether of ethylene glycol is a moderate toxic compound and that repeated skin contact or inhalation of vapour must be prevented.

Ethylene glycol monoethyl ether (cellosolve solvent; Dowanol EE; 2-ethoxyethanol). Ethylene glycol monoethyl ether is less toxic than the methyl ether (above). The most significant toxic action is on the blood, and neurological symptoms are not expected. In other respects it is similar in toxic action to ethylene glycol monomethyl ether. Excessive exposure can result in moderate irritation to the respiratory system, lung oedema, central nervous system depression and marked glomerulitis. In animal studies, foetotoxicity and teratogenicity were seen at levels above 160 ppm, and behavioural changes in offspring were obvious after maternal exposure at 100 ppm.

Other ethylene glycol ethers. Mention of ethylene glycol monobutyl ether is also in order because of its extensive use in industry. In rats, deaths in response to single oral exposures are attributable to narcosis, whereas delayed deaths result from lung congestion and renal failure. Direct contact of the eye with this ether produces intense pain, marked conjunctival irritation and corneal clouding, which may persist for several days. As with monomethyl ether, skin contact does not cause much skin irritation, but toxic amounts can be absorbed. Inhalation studies have shown that rats can tolerate 30 7-hour exposures to 54 ppm, but some injury occurs at a concentration of 100 ppm. At higher concentrations, rats exhibited haemorrhaging in the lungs, congestion of the viscera, liver damage, haemoglobinuria and marked erythrocyte fragility. Foetotoxicity has been seen in rats exposed to 100 ppm, but not at 50 ppm. Enhanced erythrocyte fragility was evident at all exposure concentrations above 50 ppm of ethylene glycol monobutyl ether vapours. Humans appear to be somewhat less susceptible than laboratory animals because of apparent resistance to its haemolytic action. While headache and eye and nasal irritation was seen in humans above 100 ppm, red blood cell damage was not found.

Both the isopropyl and n-propyl ethers of ethylene glycol present particular hazards. These glycol ethers have low single-dose oral LD50 values and they cause severe kidney and liver damage. Bloody urine is an early sign of severe kidney damage. Death usually occurs within a few days. Eye contact results in rapid conjunctival irritation and partial corneal opacity in the rabbit, with recovery requiring about 1 week. Like most other ethylene glycol ethers, the propyl derivatives are only mildly irritating to the skin but can be absorbed in toxic amounts. Furthermore, they are highly toxic via inhalation. Fortunately, ethylene glycol monoisopropyl ether is not a prominent commercial compound.

Diethylene glycol ethers. The ethers of diethylene glycol are lower in toxicity than the ethers of ethylene glycol, but they have similar characteristics.

Polyethylene glycols. Triethylene, tetraethylene, and the higher polyethylene glycols appear to be innocuous compounds of low vapour pressure.

Propylene glycol ethers. Propylene glycol monomethyl ether is relatively low in toxicity. In rats, the single oral dose LD50 caused death by generalized central nervous system depression, probably respiratory arrest. Repeated oral doses (3 g/kg) over a 35-day period induced in rats only mild histopathological changes in the liver and kidneys. Eye contact resulted in only a mild transitory irritation. It is not appreciably irritating to the skin, but confinement of large amounts of the ether to rabbit skin causes central nervous system depression. The vapour does not present a substantial health hazard if inhaled. Deep narcosis appears to be the cause of death in animals subjected to severe inhalation exposures. This ether is irritating to the eyes and upper respiratory tract of humans at concentrations that are not hazardous to health; hence it does have some warning properties.

Di- and tripropylene glycol ethers exhibit toxicological properties similar to the monopropylene derivatives, but present essentially no hazard with respect to vapour inhalation or skin contact.

Polybutylene glycols. Those that have been examined can cause kidney damage in excessive doses, but they are not injurious to the eyes or skin and are not absorbed in toxic amounts.

Acetic esters, diesters, ether esters. These derivatives of the common glycols are of particular importance since they are employed as solvents for plastics and resins in diverse products. Many explosives contain ester of ethylene glycol as a freezing-point depressant. With respect to toxicity, the glycol ether fatty acid esters are considerably more irritating to mucous membranes than the parent compounds discussed previously. However, the fatty acid esters have toxicity properties essentially identical to the parent materials once the former are absorbed, because the esters are saponified in biological environments to yield fatty acid and the corresponding glycol or glycol ether.

Safety and Health Measures

Measures used to control and limit the exposure to glycol ethers are essentially the same as those used to control solvent exposure as discussed elsewhere in this Encyclopaedia. Substitution of one material for another less toxic one, if possible, is always a good starting point. Adequate ventilation systems that can effectively minimize the concentration of material in the breathing zone is important. Where explosive and fire hazards are in issue, care must be taken to avoid open flames or sparks and to store materials in “explosion safe” containers. Personal protective equipment, such as respirators, gloves and clothing, while important, should not be relied upon exclusively. Protective eyewear should always be worn if splash exposure is a risk. When using ethylene glycol monomethyl ether, workers should wear chemical safety goggles, and adequate ventilation is necessary. Eye protection is also recommended whenever the possibility of such contact exists with ethylene glycol monobutyl ether. Inhalation of its vapours and skin contact should be avoided. Particularly when working with 2-methoxyethanol or 2-ethoxyethanol, all skin contact should be strictly avoided.

Glycol ethers tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 04:35

Fluorocarbons

The fluorocarbons are derived from hydrocarbons by the substitution of fluorine for some or all of the hydrogen atoms. Hydrocarbons in which some of the hydrogen atoms are replaced by chlorine or bromine in addition to those replaced by fluorine (e.g., chlorofluorohydrocarbons, bromofluorohydrocarbons) are generally included in the classification of fluorocarbons—for example, bromochlorodifluoromethane (CClBrF2).

The first economically important fluorocarbon was dichlorodifluoromethane (CCl2F2), which was introduced in 1931 as a refrigerant of much lower toxicity than sulphur dioxide, ammonia or chloromethane, which were the currently popular refrigerants.

Uses

In the past, fluorocarbons were used as refrigerants, aerosol propellants, solvents, foam-blowing agents, fire extinguishants and polymer intermediates. As discussed below, concerns about the effects of chlorofluorocarbons in depleting the ozone layer in the upper atmosphere have led to bans on these chemicals.

Trichlorofluoromethane and dichloromonofluoromethane were formerly used as aerosol propellants. Trichlorofluoromethane currently functions as a cleaning and degreasing agent, a refrigerant, and a blowing agent for polyurethane foams. It is also used in fire extinguishers and electric insulation, and as a dielectric fluid. Dichloromonofluoromethane is used in glass-bottle manufacture, in heat-exchange fluids, as a refrigerant for centrifugal machines, as a solvent and as a blowing agent.

Dichlorotetrafluoroethane is a solvent, diluent, and cleaning and degreasing agent for printed circuit boards. It is used as a foaming agent in fire extinguishers, a refrigerant in cooling and air-conditioning systems, as well as for magnesium refining, for inhibiting metal erosion in hydraulic fluids, and for strengthening bottles. Dichlorodifluoromethane was also used for manufacturing glass bottles; as an aerosol for cosmetics, paint and insecticides; and for the purification of water, copper and aluminium. Carbon tetrafluoride is a propellant for rockets and for satellite guidance, and tetrafluoroethylene is used in the preparation of propellants for food-product aerosols. Chloropentafluoroethane is a propellant in aerosol food preparations and a refrigerant for home appliances and mobile air conditioners. Chlorotrifluoromethane, chlorodifluoromethane, trifluoromethane, 1,1-difluoroethane and 1,1,-chlorodifluoroethane are also refrigerants.

Many of the fluorocarbons are used as chemical intermediates and solvents in varied industries, such as textiles, drycleaning, photography and plastics. In addition, a few have specific functions as corrosion inhibitors and leak detectors. Teflon is used in the manufacture of high-temperature plastics, protective clothing, tubing and sheets for chemical laboratories, electric insulators, circuit breakers, cables, wires and anti-stick coatings. Chlorotrifluoromethane is used for hardening metals, and 1,1,1,2-tetrachloro-2,2-difluoroethane and dichlorodifluoromethane are used to detect surface cracks and metal defects.

Halothane, isoflurane and enflurane are used as inhalation anaesthetics.

Environmental Hazards

In the 1970s and 1980s, evidence accumulated that stable fluorocarbons and other chemicals such as methyl bromide and 1,1,1-trichloroethane would slowly diffuse upward into the stratosphere once released, where intense ultraviolet radiation could cause the molecules to release free chlorine atoms. These chlorine atoms react with oxygen as follows:

Cl + O3 = ClO + O2

ClO + O = Cl + O2

O + O3 = 2O2

Since the chlorine atoms are regenerated in the reaction, they would be free to repeat the cycle; the net result would be a significant depletion of stratospheric ozone, which shields the earth from harmful solar ultraviolet radiation. The increase in ultraviolet radiation would result in an increase in skin cancer, affect crop yields and forest productivity, and affect the marine ecosystem. Studies of the upper atmosphere have shown areas of ozone depletion in the last decade.

As a result of this concern, beginning in 1979 nearly all aerosol products containing chlorofluorocarbons have been banned throughout the world. In 1987, an international agreement, the Montreal Protocol on Substances that Deplete the Ozone Layer, was signed. The Montreal Protocol controls the production and consumption of substances that can cause ozone depletion. It established a deadline of 1996 for totally phasing out the production and consumption of chlorofluorocarbons in developed countries. Developing countries have an additional 10 years to reach compliance. Controls were also established for halons, carbon tetrachloride, 1,1,1-trichloroethane (methyl chloroform), hydrochlorofluorocarbons (HCFCs), hydrobromofluorocarbons (HBFCs) and methyl bromide. Some essential uses for these chemicals are allowed where there are no technically and economically feasible alternatives available.

Hazards

The fluorocarbons are, in general, lower in toxicity than the corresponding chlorinated or brominated hydrocarbons. This lower toxicity may be associated with the greater stability of the CF bond, and perhaps also with the lower lipoid solubility of the more highly fluorinated materials. Because of their lower level of toxicity, it has been possible to select fluorocarbons which are safe for their intended uses. And because of the history of safe use in these applications, there has mistakenly grown up a popular belief that the fluorocarbons are completely safe under all conditions of exposure.

To a certain extent, the volatile fluorocarbons possess narcotic properties similar to, but weaker than, those shown by the chlorinated hydrocarbons. Acute inhalation of 2,500 ppm of trichlorotrifluoroethane induces intoxication and loss of psychomotor coordination in humans; this occurs at 10,000 ppm (1%) with dichlorodifluoromethane. If dichlorodifluoromethane is inhaled at 150,000 ppm (15%) , loss of consciousness results. Over 100 fatalities have been reported from the sniffing of fluorocarbons by spraying aerosol containers containing dichlorodifluoromethane as propellant into a paper bag and inhaling. At the American Conference of Governmental Industrial Hygienists (ACGIH) TLV of 1,000 ppm, narcotic effects are not experienced by humans.

Toxic effects from repeated exposure, such as liver or kidney damage, have not been produced by the fluoromethanes and fluoroethanes. The fluoroalkenes, such as tetrafluoroethylene, hexafluoropropylene or chlorotrifluoroethylene, can produce liver and kidney damage in experimental animals after prolonged and repeated exposure to appropriate concentrations.

Even the acute toxicity of the fluoroalkenes is surprising in some cases. Perfluoroisobutylene is an outstanding example. With an LC50 of 0.76 ppm for 4-hour exposures for rats, it is more toxic than phosgene. Like phosgene, it produces an acute pulmonary oedema. On the other hand, vinyl fluoride and vinylidene fluoride are fluoroalkanes of very low toxicity.

Like many other solvent vapours and surgical anaesthetics, the volatile fluorocarbons may also produce cardiac arrhythmia or arrest under circumstances where an abnormally large amount of adrenaline is secreted endogenously (such as anger, fear, excitement, severe exertion). The concentrations required to produce this effect are well above those normally encountered during the industrial use of these materials.

In dogs and monkeys, both chlorodifluoromethane and dichlorodifluoromethane cause early respiratory depression, bronchoconstriction, tachycardia, myocardial depression and hypotension at concentrations of 5 to 10%. Chlorodifluoromethane, in comparison to dichlorodifluoromethane, does not cause cardiac arrhythmias in monkeys (although it does in mice) and does not decrease pulmonary compliance in monkeys.

Safety and health measures. All fluorocarbons will undergo thermal decomposition when exposed to flame or red-hot metal. Decomposition products of the chlorofluorocarbons will include hydrofluoric and hydrochloric acid along with smaller amounts of phosgene and carbonyl fluoride. The last compound is very unstable to hydrolysis and quickly changes to hydrofluoric acid and carbon dioxide in the presence of moisture.

The three commercially most important fluorocarbons (trichlorofluoromethane, dichlorodifluoromethane and trichlorotrifluoroethane) have been tested for mutagenicity and teratogenicity with negative results. Chlorodifluoromethane, which received some consideration as a possible aerosol propellant, was found to be mutagenic in bacterial mutagenicity tests. Lifetime exposure tests gave some evidence of carcinogenicity in male rats exposed to 50,000 ppm (5%), but not 10,000 ppm (1%). The effect was not seen in female rats or in other species. The International Agency for Research on Cancer (IARC) has classified it in Group 3 (limited evidence of carcinogenicity in animals), There was some evidence of teratogenicity in rats exposed to 50,000 ppm (5%), but not at 10,000 ppm (1%), and there was no evidence in rabbits at up to 50,000 ppm.

Victims of fluorocarbon exposure should be removed from the contaminated environment and treated symptomatically. Adrenaline should not be administered, because of the possibility of inducing cardiac arrhythmias or arrest.

Tetrafluoroethylene

The principal hazards of tetrafluoroethylene monomer are its flammability over a wide range of concentrations (11 to 60%) and potential explosivity. Uninhibited tetrafluoroethylene is liable to spontaneous polymerization and/or dimerization, both of which reactions are exothermic. The consequent pressure rise in a closed container can result in an explosion, and a number of such have been reported. It is thought that these spontaneous reactions are initiated by active impurities such as oxygen.

Tetrafluoroethylene does not present much of an acute toxic hazard per se, the LC50 for 4-hour exposure of rats being 40,000 ppm. Rats dying from lethal exposures show not only damage to the lungs, but also degenerative changes in the kidney, the latter also being exhibited by other fluoroalkenes but not by fluoroalkanes.

Another hazard relates to the toxic impurities formed during the preparation or pyrolysis of tetrafluoroethylene, particularly octafluoroisobutylene, which has an approximate lethal concentration of only 0.76 ppm for 4-hour exposure of rats. A few fatalities have been described from exposure to these “high boilers”. Because of the potential dangers, casual experiments with tetrafluoroethylene should not be undertaken by the unskilled.

Safety and health measures. Tetrafluoroethylene is transported and shipped in steel cylinders under high pressure. Under such conditions the monomer should be inhibited to prevent spontaneous polymerization or dimerization. Cylinders should be fitted with pressure-relief devices, although it should not be overlooked that such devices may become plugged with polymer.

Teflon (polytetrafluoroethylene) is synthesized by the polymerization of tetrafluoroethylene with a redox catalyst. Teflon is not a hazard at room temperature. However, if it is heated to 300 to 500 °C, pyrolysis products include hydrogen fluoride and octafluoroisobutylene. At higher temperatures, 500 to 800 °C, carbonyl fluoride is produced. Above 650 °C, carbon tetrafluoride and carbon dioxide are produced. It can cause polymer fume fever, a flu-like illness. The most common cause of illness is from lit cigarettes contaminated with Teflon dust. Pulmonary oedema has also been reported.

Fluorocarbon anaesthetics. Halothane is an older inhalation anaesthetic, often used in combination with nitrous oxide. Isoflurane and enflurane are becoming more popular because they have fewer reported side-effects than halothane.

Halothane produces anaesthesia at concentrations above 6,000 ppm. Exposure to 1,000 ppm for 30 minutes causes abnormalities in behavioural tests which do not occur at 200 ppm. There are no reports of skin, eye or respiratory irritation or sensitization. Hepatitis has been reported at sub-anaesthetic concentrations, and severe—sometimes fatal—hepatitis has occurred in patients repeatedly exposed to anaesthetic concentrations. Liver toxicity has not been found from occupational exposures to isoflurane or enflurane. Hepatitis has occurred in patients exposed to 6,000 ppm of enflurane or higher; cases have been also been reported from use of isoflurane, but its role has not been proven.

One animal study of liver toxicity found no toxic effects in rats repeatedly exposed to 100 ppm of halothane in air; another study found brain, liver and kidney necrosis at 10 ppm, according to electron microscopy observations. No effects were found in mice exposed to 1,000 ppm of enflurane for 4 hours/day for about 70 days; a slight reduction in body weight gain was the only effect found when they were exposed to 3,000 ppm for 4 hours/day, 5 days/week for up to 78 weeks. In another study, severe weight loss and deaths with liver damage were found in mice exposed continuously to 700 ppm of enflurane for up to 17 days; in the same study, no effects were seen in rats or guinea pigs exposed for 5 weeks. With isoflurane, continuous exposure of mice to 150 ppm and above in air caused reduced body weight gain. Similar effects were seen in guinea pigs, but not rats, at 1,500 ppm. No significant effect was seen in mice exposed 4 hours/day, 5 days/week for 9 weeks at up to 1,500 ppm.

No evidence of mutagenicity or carcinogenicity was found in animal studies of enflurane or isoflurane, or in epidemiological studies of halothane. Early epidemiological studies suggesting adverse reproductive effects from halothane and other inhalation anaesthetics have not been verified for halothane exposure in subsequent studies.

No convincing evidence of foetal effects was found in rats with halothane exposures up to 800 ppm, and no effect on fertility with repeated exposures up to 1,700 ppm. There was some foetotoxicity (but not teratogenicity) at 1,600 ppm and over. In mice, there was foetotoxicity at 1,000 ppm but not 500 ppm. Reproductive studies of enflurane found no effects on fertility in mice at concentrations up to 10,000 ppm, with some evidence of sperm abnormality at 12,000 ppm. There was no evidence of teratogenicity in mice exposed up to 7,500 ppm or in rats at up to 5,000 ppm. There was slight evidence of embryo/foetotoxicity in pregnant rats exposed to 1,500 ppm. With isoflurane, exposure of male mice at up to 4,000 ppm for 4 hours/day for 42 days had no effect on fertility. There were no foetotoxic effects in pregnant mice exposed at 4,000 ppm for 4 hours/day for 2 weeks; exposure of pregnant rats to 10,500 ppm produced minor loss of foetal body weight. In another study, decreased litter size and foetal body weight and developmental effects were found in the foetuses of mice exposed to 6,000 ppm of isoflurane for 4 hours/day on days 6 to 15 of pregnancy; no effects were found at 60 or 600 ppm.

Fluorocarbons tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 01:21

Ethers

Ethers are organic compounds in which oxygen serves as a link between two organic radicals. Most of the ethers of industrial importance are liquids, although methyl ether is a gas and a number of ethers, for example the cellulose ethers, are solids.

Hazards

The lower-molecular-weight ethers (methyl, diethyl, isopropyl, vinyl and vinyl isopropyl) are highly flammable, with flashpoints below normal room temperatures. Accordingly, measures should be taken to avoid release of vapours into areas where means of ignition may exist. All sources of ignition should be eliminated in areas where appreciable concentrations of ether vapour may be present in normal operations, as in drying ovens, or where there may be accidental release of the ether either as a vapour or as a liquid. Further control measures should be observed.

On prolonged storage in the presence of air or in sunlight, ethers are subject to peroxide formation that involves a possible explosion hazard. In laboratories, amber glass bottles provide protection, except from ultraviolet radiation or direct sunlight. Inhibitors such as copper mesh or a small amount of reducing agent may not be wholly effective. If a dry ether is not required, 10% of the ether volume of water may be added. Agitation with 5% aqueous ferrous sulphate removes peroxides. The primary toxicological characteristics of the non-substituted ethers is their narcotic action, which causes them to produce loss of consciousness on appreciable exposure; and, as good fat solvents, they cause dermatitis on repeated or prolonged skin contact. Enclosure and ventilation are to be employed to avoid excessive exposure. Barrier creams and impervious gloves assist in preventing skin irritation. In the event of loss of consciousness, the person should be removed from the contaminated atmosphere and given artifical respiration and oxygen.

The principal physiological effect of the unhalogenated ethers shown in the accompanying tables is anaesthesia. At high exposures, such as repeated exposures in excess of 400 ppm to ethyl ether, nasal irritation, loss of appetite, headache, dizziness and excitation, followed by sleepiness may result. Repeated contact with the skin may cause it to become dry and cracked. Following long-term exposures, it has been reported that mental disorders may occur.

Halogenated ethers

In contrast to the unhalogenated ethers, the halogenated ethers represent serious industrial hazards. They share the chemical property of being aklylating agents—that is, they can chemically bind alkyl groups, such as ethyl- and methyl- groups to available electron donor sites (e.g., -NH2 in genetic material and haemoglobin). Such alklyation is believed to be intimately related to the induction of cancer and is discussed more fully elsewhere in this Encyclopaedia.

Bis(chloromethyl) ether (BCME) is a known human carcinogen (Group 1 classification by the International Agency for Research on Cancer (IARC)). It is also an extremely irritating substance. The carcinogenic effects of BCME have been observed in workers exposed to the substance for a relatively short period of time. This reduced latency period is probably related to the potency of the agent.

Chloromethyl methyl ether (CMME) is also a known human carcinogen which is intensely irritating as well. Exposure to the vapours of CMME even at levels of 100 ppm can be life threatening. Workers exposed to such levels have experienced serious respiratory effects, including pulmonary oedema.

Unless there is evidence to the contrary, it is prudent to treat all halogenated ethers prudently and to consider all alkylating agents potential carcinogens unless there is evidence to the contrary. The glycidyl ethers are considered in the family entitled “Epoxy compounds” .

Ethers tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

Halogenated ethers tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 01:07

Esters, Alkanoates (except Acetates)

Uses

The acrylate esters are used in the manufacture of leather finish resins and textile, plastic and paper coatings. Methyl acrylate, producing the hardest resin of the acrylate ester series, is used in the manufacture of acrylic fibres as a co-monomer of acrylonitrile because its presence facilitates the spinning of fibres. It is used in dentistry, medicine and pharmaceuticals, and for the polymerization of radioactive waste. Methyl acrylate is also utilized in the purification of industrial effluents and in the timed release and disintegration of pesticides. Ethyl acrylate is a component of emulsion and solution polymers for surface-coating textiles, paper and leather. It is also used in synthetic flavouring and fragrances; as a pulp additive in floor polishes and sealants; in shoe polishes; and in the production of acrylic fibres, adhesives and binders.

More than 50% of the methyl methacrylate produced is utilized for the production of acrylic polymers. In the form of polymethylmethacrylate and other resins, it is used mainly as plastic sheets, moulding and extrusion powders, surface coating resins, emulsion polymers, fibres, inks and films. Methyl methacrylate is also useful in the production of the products known as Plexiglas or Lucite. They are used in plastic dentures, hard contact lenses and cement. n-Butyl methacrylate is a monomer for resins, solvent coatings, adhesives and oil additives, and it is used in emulsions for textiles, leather and paper finishing, and in the manufacture of contact lenses.

Hazards

As with many monomers—that is, chemicals which are polymerized to form plastics and resins—the reactivity of acrylates can pose occupational health and safety hazards if sufficient levels of exposure exist. Methyl acrylate is highly irritating and can cause sensitization. There is some evidence that chronic exposure may damage liver and kidney tissue. Evidence of carcinogencity is inconclusive (Group 3—Unclassifiable, according to the International Agency for Research on Cancer (IARC)). By contrast, ethyl acrylate is rated as a Group 2B carcinogen (possible human carcinogen). Its vapours are highly irritating to the nose, eyes and respiratory tract. It can cause corneal lesions, and inspiration of high concentrations of the vapours can lead to pulmonary oedema. Some skin sensitization following contact with liquid ethyl acrylate has been reported.

Butyl acrylate shares similar biological properties with methyl and ethyl acrylate, but the toxicity appears to decrease with an increase in molecular weight. It too is an irritating substance capable of causing sensitization after skin contact with the liquid.

The methacrylates resemble the acrylates, but are less biologically active. There is some evidence that the substance does not cause cancer in animals. Methyl methacrylate can act as a central nervous system depressant, and there are reports of sensitization among workers exposed to the monomer. Ethyl methacrylate shares properties of methyl methacrylate but is much less irritating. As with the acrylates, the methacrylates decrease in biological potency with increasing molecular weight, and butyl methacrylate, while an irritant, is less irritating than ethyl methacrylate.

Acrylates tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 01:01

Esters, Acrylates

Uses

The acrylate esters are used in the manufacture of leather finish resins and textile, plastic and paper coatings. Methyl acrylate, producing the hardest resin of the acrylate ester series, is used in the manufacture of acrylic fibres as a co-monomer of acrylonitrile because its presence facilitates the spinning of fibres. It is used in dentistry, medicine and pharmaceuticals, and for the polymerization of radioactive waste. Methyl acrylate is also utilized in the purification of industrial effluents and in the timed release and disintegration of pesticides. Ethyl acrylate is a component of emulsion and solution polymers for surface-coating textiles, paper and leather. It is also used in synthetic flavouring and fragrances; as a pulp additive in floor polishes and sealants; in shoe polishes; and in the production of acrylic fibres, adhesives and binders.

More than 50% of the methyl methacrylate produced is utilized for the production of acrylic polymers. In the form of polymethylmethacrylate and other resins, it is used mainly as plastic sheets, moulding and extrusion powders, surface coating resins, emulsion polymers, fibres, inks and films. Methyl methacrylate is also useful in the production of the products known as Plexiglas or Lucite. They are used in plastic dentures, hard contact lenses and cement. n-Butyl methacrylate is a monomer for resins, solvent coatings, adhesives and oil additives, and it is used in emulsions for textiles, leather and paper finishing, and in the manufacture of contact lenses.

Hazards

As with many monomers—that is, chemicals which are polymerized to form plastics and resins—the reactivity of acrylates can pose occupational health and safety hazards if sufficient levels of exposure exist. Methyl acrylate is highly irritating and can cause sensitization. There is some evidence that chronic exposure may damage liver and kidney tissue. Evidence of carcinogencity is inconclusive (Group 3—Unclassifiable, according to the International Agency for Research on Cancer (IARC)). By contrast, ethyl acrylate is rated as a Group 2B carcinogen (possible human carcinogen). Its vapours are highly irritating to the nose, eyes and respiratory tract. It can cause corneal lesions, and inspiration of high concentrations of the vapours can lead to pulmonary oedema. Some skin sensitization following contact with liquid ethyl acrylate has been reported.

Butyl acrylate shares similar biological properties with methyl and ethyl acrylate, but the toxicity appears to decrease with an increase in molecular weight. It too is an irritating substance capable of causing sensitization after skin contact with the liquid.

The methacrylates resemble the acrylates, but are less biologically active. There is some evidence that the substance does not cause cancer in animals. Methyl methacrylate can act as a central nervous system depressant, and there are reports of sensitization among workers exposed to the monomer. Ethyl methacrylate shares properties of methyl methacrylate but is much less irritating. As with the acrylates, the methacrylates decrease in biological potency with increasing molecular weight, and butyl methacrylate, while an irritant, is less irritating than ethyl methacrylate.

Acrylates tables

Table 1- Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 00:58

Esters, Acetates

Acetates are derived from a reaction (called esterification) between acetic acid or an anhydrous compound containing an acetate group and the corresponding alcohol, with the elimination of water. Thus methyl acetate is obtained by the esterification of methyl alcohol with acetic acid in the presence of sulphuric acid as a catalyst. The reaction is reversible and must therefore be conducted with heat, eliminating water formed by the reaction. Ethyl acetate is obtained by the direct esterification of ethyl alcohol with acetic acid, a process which involves mixing acetic acid with an excess of ethyl alcohol and adding a small amount of sulphuric acid. The ester is separated and purified by distillation. Ethyl acetate is easily hydrolyzed in water, giving a slightly acid reaction. In another process the molecules of anhydrous acetaldehyde interact in the presence of aluminium ethoxide to produce the ester, which is purified by distillation. Propyl acetate and isopropyl acetate esters are produced by the reaction of acetic acid with the corresponding propyl alcohol in the presence of a catalyst.

Both butyl acetate and amyl acetate consist of mixtures of isomers. Thus butyl acetate comprises n-butyl acetate, sec-butyl acetate and isobutyl acetate. It is made by the esterification of n-butanol with acetic acid in the presence of sulphuric acid. n-Butanol is obtained by the fermentation of starch with Clostridium acetobutylicum. Amyl acetate is primarily a mixture of n-amyl acetate and isoamyl acetate. Its composition and characteristics depend on its grade. The flashpoints of the various grades vary from 17 to 35 °C.

Uses

The acetates are solvents for nitrocellulose, lacquers, leather finishes, paints and plastics. They are also used as flavouring agents and preservatives in the food industry, and fragrances and solvents in the perfume and cosmetics industries. Methyl acetate, generally mixed with acetone and methyl alcohol, is used in the plastics and artificial leather industries, and in the production of perfumes, colouring agents and lacquers. Ethyl acetate is a good solvent for nitrocellulose, fats, varnishes, lacquers, inks and airplane dopes; it is used in the production of smokeless powder, artificial leather, perfumes, photographic films and plates, and artificial silk. It is also a cleaning agent in the textile industry, and a flavouring agent for pharmaceuticals and food.

n-Propyl acetate and isopropyl acetate are solvents for plastics, inks and nitrocellulose in the production of lacquers. They are utilized in the manufacture of perfumes and insecticides, and in organic synthesis. Butyl acetate is a commonly used solvent in the production of nitrocellulose lacquers. It is also used in the manufacture of vinyl resins, artificial leather, photographic film, perfumes, and in the preserving of foodstuffs.

In its commercial form amyl acetate, a mixture of isomers, is used as a solvent for nitrocellulose in the manufacture of lacquers, and, because of its banana-like smell, it is used as a fragrance. Amyl acetate is useful in the manufacture of artificial leather, photographic film, artificial glass, celluloid, artificial silk, and furniture polish. Isoamyl acetate is used for dyeing and finishing textiles, perfuming shoe polish, and manufacturing artificial silk, leather, pearls, photographic films, celluloid cements, waterproof varnish and metallic paints. It is also used in artificial glass manufacturing and in the straw hat industry as a constituent of lacquers and stiffening solutions. Sodium acetate in used in tanning, photography, electroplating and preserving meat, as well as in the manufacture of soaps and pharmaceuticals.

Vinyl acetate primarily functions as an intermediate for the production of polyvinyl alcohol and polyvinyl acetals. It is also used in hair sprays and in the production of emulsion paint substances, finishing and impregnation materials, and glue. 2-Pentyl acetate has many of the same functions as the other acetates and serves as a solvent for chlorinated rubber, metallic paints, cements, linoleum, washable wallpaper, pearls, and coatings on artificial pearls.

Hazards

Methyl acetate is flammable, and its vapour forms explosive mixtures with air at normal temperatures. High concentrations of vapour can cause irritation to the eyes and mucous membranes. Exposure to the vapours can also cause headache, drowsiness, dizziness, burning and tearing of the eyes, heart palpitations, as well as a constricted feeling in the chest and shortness of breath. Blindness arising from eye contact has also been reported.

Ethyl acetate is a flammable liquid and produces a vapour that forms explosive mixtures with air at normal temperatures. Ethyl acetate is an irritant of the conjunctive and mucous membrane of the respiratory tract. Animal experiments have shown that, at very high concentrations, the ester has narcotic and lethal effects; at concentrations of 20,000 to 43,000 ppm, there may be pulmonary oedema with haemorrhages, symptoms of central nervous system depression, secondary anaemia and damage of the liver. Lower concentrations in humans have caused irritation of the nose and pharynx; cases have also been known of irritation of the conjunctiva with temporary opacity of the cornea. In rare cases exposure may cause sensitization of the mucous membrane and eruptions of the skin.

The irritant effect of ethyl acetate is less strong than that of propyl acetate or butyl acetate. These two propyl acetate isomers are flammable, and their vapours form explosive mixtures with air at normal temperatures. Concentrations of 200 ppm can cause irritation of the eyes, and greater concentrations give rise to irritation of the nose and larynx. Amongst workers occupationally exposed to these esters, there have been cases of conjunctival irritation and reports of a feeling of constriction of the chest, and coughing; however, no cases of permanent or systemic effects have been found in exposed workers. Repeated contact of the liquid with the skin may lead to defatting and cracking.

Amyl acetate. All the isomers and grades of amyl acetate are flammable and evolve flammable mixtures of vapour in air. High concentrations (10,000 ppm for 5 h) can be lethal to guinea-pigs. The principal symptoms in cases of occupational exposure are headaches and irritation of the mucous membranes of the nose and of the conjunctiva. Other symptoms mentioned include vertigo, palpitations, gastrointestinal disorders, anaemia, cutaneous lesions, dermatitis and adverse effects on the liver. Amyl acetate is also a defatting agent, and prolonged exposure may produce dermatitis. Butyl acetate is significantly more irritating than ethyl acetate. In addition, it can exert behavioural symptoms similar to amyl acetate.

Hexyl acetate and benzyl acetate are used industrially and are flammable, but their vapour pressures are low and, unless they are heated, they are unlikely to produce flammable concentrations of vapour. Animal experiments indicate that the toxic properties of these acetates are greater than those of amyl acetate; however, in practice, due to their low volatility, their effect on workers is limited to local irritation. There are few data upon which to evaluate hazards.

Cyclohexyl acetate can exert extreme narcotic effects in animals and appears to be a stronger irritant experimentally that is amyl acetate; however, there are insufficient data on human exposure to evaluate. The chemical does not tend to accumulate in the body, and many effects appear to be reversible.

Vinyl acetate is transformed metabolically into acetaldehyde, which raises a question of carcinogenicity. Based on this and on the positive results of animal assays, the International Agency for Research on Cancer (IARC) has classified vinyl acetate as a Group 2B carcinogen, possibly carcinogenic to humans. In addition, the chemical can be irritating to the upper respiratory tract and eyes. It is defatting to the skin.

Acetates tables

Table 1- Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 00:39

Epoxy Compounds

Epoxy compounds are those that consist of oxirane rings (either one or more). An oxirane ring is essentially one oxygen atom linked to two carbon atoms. These will react with amino, hydroxyl and carboxyl groups as well as inorganic acids to yield relatively stable compounds.

Uses

Epoxy compounds have found wide industrial use as chemical intermediates in the manufacture of solvents, plasticizers, cements, adhesives and synthetic resins. They are commonly used in various industries as protective coatings for metal and wood. The alpha-epoxy compounds, with the epoxy group (C-O-C) in the 1,2 position, are the most reactive of the epoxy compounds and are primarily used in industrial applications. The epoxy resins, when converted by curing agents, yield highly versatile, thermosetting materials used in a variety of applications including surface coatings, electronics (potting compounds), laminating, and bonding together of a wide variety of materials.

Butylene oxides (1,2-epoxybutane and 2,3-epoxybutane) are used for the production of butylene glycols and their derivatives, as well as for the manufacture of surface active agents. Epichlorohydrin is a chemical intermediate, insecticide, fumigant and solvent for paints, varnishes, nail enamels and lacquers. It is also used in polymer coating material in the water supply system and in raw material for high wet-strength resins for the paper industry. Glycidol (or 2,3-epoxypropanol) is a stabilizer for natural oils and vinyl polymers, a dye-leveling agent and an emulsifier.

1,2,3,4-Diepoxybutane. Short-term (4-hour) inhalation studies with rats have caused watering of the eyes, clouding of the cornea, laboured breathing and lung congestion. Experiments in other animal species have demonstrated that diepoxybutane, like many of the other epoxy compounds, can cause eye irritation, burns and blisters of the skin, and irritation of the pulmonary system. In humans, accidental “minor” exposure caused swelling of the eyelids, upper respiratory tract irritation, and painful eye irritation 6 hours after exposure.

Skin application of D,L- and the meso- forms of 1,2,3,4-diepoxybutane have produced skin tumours, including squamous-cell skin carcinomas, in mice. The D- and L- isomers have produced local sarcomas in mice and rats by subcutaneous and intraperitoneal injection respectively.

Several epoxy compounds are employed in the health care and food industries. Ethylene oxide is used to sterilize surgical instruments and hospital equipment, fabric, paper products, sheets and grooming instruments. It is also a fumigant for foodstuffs and textiles, a rocket propellant, and a growth accelerator for tobacco leaves. Ethylene oxide is used as an intermediary in the production of ethylene glycol, polyethylene terephthalate polyester film and fibre, and other organic compounds. Guaiacol is a local anaesthetic agent, antioxidant, stimulant expectorant, and a chemical intermediate for other expectorants. It is used as a flavouring agent for non-alcoholic beverages and food. Propylene oxide, or 1,2-epoxypropane, has been used as a fumigant for the sterilization of packaged food products and other materials. It is a highly reactive intermediary in the production of polyether polyols, which, in turn, are used to make polyurethane foams. The chemical is also used in the production of propylene glycol and its derivatives.

Vinylcyclohexene dioxide is used as a reactive diluent for other diepoxides and for resins derived from epichlorohydrin and bisphenol A. Its use as a monomer for the preparation of polyglycols containing free epoxide groups or for polymerization to a tridimensional resin has been investigated.

Furfural is used in screening tests for urine, solvent refining of petroleum oils, and manufacturing of varnishes. It is a synthetic flavouring agent, a solvent for nitrated cotton, a constituent of rubber cements, and a wetting agent in the manufacture of abrasive wheels and brake linings. Furfuryl alcohol is also a flavouring agent, as well as a liquid propellant and solvent for dyes and resins. It is used in corrosive-resistant sealants and cements, and foundry cores. Tetrahydrofuran is used in histology, chemical synthesis, and in the fabrication of articles for packaging, transporting and storing foods. It is a solvent for fat oils and unvulcanized rubber. Diepoxybutane has been used to prevent spoilage of foodstuffs, as a polymer curing agent, and for cross-linking textile fibres.

Hazards

There are numerous epoxy compounds in use today. Specific commonly used ones are individually discussed below. There are, however, certain characteristic hazards shared by the group. In general, the toxicity of a resin system is a complicated interplay between the individual toxicities of its various component ingredients. The compounds are known sensitizers of the skin, and those with the highest sensitization potential are those of lower relative molecular weight. Low molecular weight is also generally associated with increased volatility. Delayed and immediate allergic epoxy dermatitis and irritant epoxy dermatitis have all been reported. The dermatitis usually first develops on the hands between the digits, and can range in severity from erythema to marked bullous eruption. Other target organs reportedly adversely affected by epoxy compound exposure include the central nervous sysstem (CNS), the lungs, the kidneys, the reproductive organs, the blood and the eyes. There is also evidence that certain epoxy compounds have mutagenic potential. In one study, 39 of the 51 epoxy compounds tested induced a positive response in the Ames/Salmonella assay. Other epoxides have been shown to induce sister-chromatid exchanges in human lymphocytes. Animal studies looking at associated epoxide exposures and cancers are ongoing.

It should be noted that certain of the curing agents, hardeners and other processing agents used in the production of the final compounds have associated toxicities as well. One in particular, 4,4-methylenedianiline (MDA), is associated with hepatotoxicity and with damage to the retina of the eye, and has been known to be an animal carcinogen. Another is trimellitic anhydride (TMA). Both are discussed elsewhere in this chapter.

One epoxy compound, epichlorohydrin, has been reported to cause a significant increase of pulmonary cancer in exposed workers. This chemical is classified as a Group 2A chemical, probably carcinogenic to humans, by the International Agency for Research on Cancer (IARC). One long-term epidemiological study of workers exposed to epichlorohydrin at two US facilities of the Shell Chemical Company was reported to demonstrate a statistically significant (p < .05) increase in deaths due to respiratory cancer. Like the other epoxy compounds, epichlorohydrin is irritating to the eyes, skin and respiratory tract of exposed individuals. Human and animal evidence has demonstrated that epichlorohydrin may induce severe skin damage and systemic poisoning following extended dermal contact. Exposures to epichlorohydrin at 40 ppm for 1 h have been reported to cause eye and throat irritation lasting 48 h, and at 20 ppm caused temporary burning of the eyes and nasal passages. Epichlorohydrin-induced sterility in animals has been reported, as have liver and kidney damage.

Subcutaneous injection of epichlorohydrin has produced tumours in mice at the injection site but has not produced tumours in mice by skin-painting assay. Inhalation studies with rats have shown a statistically significant increase in nasal cancer. Epichlorohydrin has induced mutations (base-pair substitution) in microbial species. Increases in the chromosomal aberrations found in the white blood cells of workers exposed to epichlorohydrin have been reported. As of 1996 the American Conference of Governmental Industrial Hygienists (ACGIH) established a TLV of 0.5 ppm, and it is considered an A3 carcinogen (animal carcinogen).

1,2-Epoxybutane and isomers (butylene oxides). These compounds are less volatile and less toxic than propylene oxide. The major documented adverse effects in humans have been irritation of the eyes, nasal passages and skin. In animals, however, respiratory problems, pulmonary haemorrhage, nephrosis and nasal-cavity lesions were noted in acute exposures to very high concentrations of 1,2-epoxybutane. No consistent teratogenic effects have been demonstrated in animals. IARC has determined that there is limited evidence for the carcinogenicity of 1,2-epoxybutane in experimental animals.

When 1,2-epoxypropane (propylene oxide) is compared to ethylene oxide, another epoxy compound commonly used in sterilization of surgical/hospital supplies, propylene oxide is considered to be far less toxic to humans. Exposure to this chemical has been associated with irritant effects on the eyes and skin, respiratory tract irritation, and CNS depression, ataxia, stupor and coma (the latter effects have thus far been significantly demonstrated only in animals). In addition, 1,2-epoxypropane has been shown to act as a direct alkylating agent in various tissues, and thus the possibility of carcinogenic potential is raised. Several animal studies have strongly implicated the compound’s carcinogenicity as well. The major adverse effects which have thus far been definitively demonstrated in humans involve burning or blistering of the skin when prolonged contact with non-volatilized chemical has occurred. This has been shown to occur even with low concentrations of propylene oxide. Corneal burns attributed to the chemical have also been reported.

Vinylcyclohexene dioxide. The irritation produced by the pure compound after application on rabbit skin resembles the oedema and reddening of first-degree burns. Skin application of vinylcyclohexene dioxide in mice produces a carcinogenic effect (squamous-cell carcinomas or sarcomas); intraperitoneal administration in rats caused analogous effects (sarcomas of the peritoneal cavity). The substance has proved to be mutagenic in Salmonella typhimurium TA 100; it also produced a significant increase in mutations in Chinese hamster cells. It should be treated as a substance with carcinogenic potential, and appropriate engineering and hygienic controls should be in place.

In industrial experience vinylcyclohexene dioxide has been shown to have skin irritant properties and to cause dermatitis: a severe vesiculation of both feet has been observed in a worker who had put on shoes contaminated by the compound. Eye injury is also a definite hazard. Studies on chronic effects are not available.

2,3-Epoxypropanol. Based on experimental studies with mice and rats, glycidol was found to cause eye and lung irritation. The LC50 for a 4-h exposure of mice was found to be 450 ppm, and for an 8-h exposure of rats it was 580 ppm. However, at concentrations of 400 ppm of glycidol, rats exposed for 7 h a day for 50 days showed no evidence of systemic toxicity. After the first few exposures, slight eye irritation and respiratory distress were noted.

Ethylene oxide (ETO) is a highly dangerous and toxic chemical. It reacts exothermically and is potentially explosive when heated or placed in contact with alkali metal hydroxides or highly active catalytic surfaces. Therefore when in use in industrial areas it is best if it is tightly controlled and confined to closed or automated processes. The liquid form of ethylene oxide is relatively stable. The vapour form, in concentrations as low as 3%, is very flammable and potentially explosive in the presence of heat or flame.

A wealth of information exists regarding the possible human health effects of this compound. Ethylene oxide is a respiratory, skin and eye irritant. At high concentrations it is also associated with central nervous system depression. Some individuals exposed to high concentrations of the chemical have described a strange taste in their mouths after the exposure. Delayed effects of high acute exposures include headache, nausea, vomiting, shortness of breath, cyanosis and pulmonary oedema. Additional symptoms that have been reported after acute exposures include drowsiness, fatigue, weakness and incoordination. Ethylene oxide solution can cause a characteristic burn on exposed skin anywhere from 1 to 5 h post-exposure. This burn often progresses from vesicles to coalescent blebs and desquamation. The skin wounds will often spontaneously resolve, with increased pigmentation resulting at the burn site.

Chronic or low-to-moderate prolonged exposures to ethylene oxide are associated with mutagenic activity. It is known to act as an alkylating agent in biological systems, binding to the genetic material and other electron-donating sites, such as haemoglobin, and causing mutations and other functional damage. ETO is associated with chromosomal damage. The ability of damaged DNA to repair itself was adversely affected by low but prolonged exposure to ETO in one study of exposed human subjects. Some studies have linked ETO exposure with increased absolute lymphocyte counts in exposed workers; however, recent studies are not supportive of this association.

The carcinogenic potential of ethylene oxide has been demonstrated in several animal models. IARC has classified ethylene oxide as a Group 1 known human carcinogen. Leukaemia, peritoneal mesothelioma and certain brain tumours have been associated with long-term inhalation of ETO in rats and monkeys. Studies of exposure in mice have linked inhalation exposures to lung cancers and lymphomas. Both the US National Institute for Occupational Safety and Health (NIOSH) and the US Occupational Safety and Health Administration (OSHA) have concluded that ethylene oxide is a human carcinogen. The former conducted a large-scale study of over 18,000 ETO-exposed workers over a 16-year period and determined that the exposed individuals had greater than expected rates of blood and lymph cancers. Subsequent studies have found that no increased rates of these cancers have been associated with exposed workers. One of the major problems with these studies, and a possible reason for their contradictory nature, has been the inability to accurately quantify levels of exposure. For example, much of the available research on human carcinogenic effects of ETO has been done using exposed hospital sterilizer operators. Individuals who worked in these jobs prior to the 1970s most likely experienced higher exposures to ETO gas due to the technology and lack of local control measures in place at that time. (Safeguards in the use of ETO in health care settings are discussed in the Health care facilities and services chapter in this volume.)

Ethylene oxide has also been associated with adverse reproductive effects in both animals and humans. Dominant lethal mutations in reproductive cells have resulted in higher embryonic death rates in the offspring of ETO-exposed male and female mice and rats. Some studies have linked ethylene oxide exposure to increased rates of miscarriage in humans.

Adverse neurological and neuropsychiatric effects resulting from ethylene oxide exposure have been reported in animals and humans. Rats, rabbits and monkeys exposed to 357 ppm of ETO over a period of 48 to 85 days developed impairment of sensory and motor function, and muscle wasting and weakness of the hind limbs. One study found that human workers exposed to ETO demonstrated impaired vibratory sense and hypoactive deep tendon reflexes. The evidence of impaired neuropsychiatric functioning in humans exposed to low but prolonged levels of ethylene oxide is uncertain. Some studies and an increasing body of anecdotal evidence suggest that ETO is linked to CNS dysfunction and cognitive impairment—for example, clouded thinking, memory problems and slowed reaction times on certain types of tests.

One study of individuals exposed to ethylene oxide in a hospital setting suggested an association between that exposure and the development of ocular cataracts.

An additional hazard associated with exposure to ethylene oxide is the potential for the formation of ethylene chlorohydrin (2-chloroethanol), which may be formed in the presence of moisture and chloride ions. Ethylene chlorohydrin is a severe systemic poison, and exposure to the vapour has caused human fatalities.

Tetrahydrofuran (THF) forms explosive peroxides when exposed to air. Explosions may also occur when the compound is brought into contact with lithium-aluminium alloys. Its vapour and peroxides may cause irritation of the mucous membranes and skin, and it is a strong narcotic.

While limited data are available on the industrial experiences with THF, it is interesting to note that investigators that were engaged in animal experiments with this compound complained of severe occipital headaches and dullness after each experiment. Animals subjected to lethal doses of tetrahydrofuran fell into narcosis quickly, which was accompanied by muscular hypotonia and disappearance of corneal reflexes, and followed by coma and death. Single toxic doses caused giddiness, irritation of mucous membranes with copious flow of saliva and mucous, vomiting, a marked fall in blood pressure, and muscular relaxation, followed by prolonged sleep. Generally, the animals recovered from these doses and showed no evidence of biological changes. After repeated exposures, the effects included irritation of the mucous membranes, which may be followed by renal and hepatic alteration. Alcoholic beverages enhance the toxic effect.

Safety and Health Measures

The primary purposes of control measures for the epoxy compounds should be to reduce the potential for inhalation and skin contact. Wherever feasible, control at the source of contamination should be implemented with enclosure of the operation and/or the application of local exhaust ventilation. Where such engineering controls are not sufficient to reduce airborne concentrations to acceptable levels, respirators may be necessary to prevent pulmonary irritation and sensitization in exposed workers. Preferred respirators include gas masks with organic vapour cannisters and high-efficiency particulate filters or supplied-air respirators. All body surfaces should be protected against contact with epoxy compounds through the use of gloves, aprons, face shields, goggles and other protective equipment and clothing as necessary. Contaminated clothing should be removed as soon as possible and the affected areas of the skin washed with soap and water.

Safety showers, eyewash fountains and fire extinguishers should be located in areas where appreciable amounts of epoxy compounds are in use. Handwashing facilities, soap and water should be made available to involved employees.

The potential fire hazards associated with epoxy compounds suggest that no flames or other sources of ignition, such as smoking, be permitted in areas where the compounds are stored or handled.

Affected workers should, as necessary, be removed from emergency situations, and if the eyes or skin have been contaminated they should be flushed with water. Contaminated clothing should be promptly removed. If exposure is severe, hospitalization and observation for 72 h for delayed onset of severe pulmonary oedema is advisable.

When the epoxy compounds, such as ethylene oxide, are extremely volatile, stringent safeguards should be taken to prevent fire and explosion. These safeguards should include the control of ignition sources, including static electricity; the availability of foam, carbon dioxide or dry chemical fire extinguishers (if water is used on large fires, the hose should be equipped with a fogging nozzle); the use of steam or hot water to heat ethylene oxide or its mixtures; and storage away from heat and strong oxidizers, strong acids, alkalis, anhydrous chlorides or iron, aluminium or tin, iron oxide, and aluminium oxide.

Proper emergency procedures and protective equipment should be available to deal with spills or leaks of ethylene oxide. In case of a spill, the first step is to evacuate all personnel except those involved in the clean-up operations. All ignition sources in the area should be removed or shut down and the area well ventilated. Small quantities of spilled liquid can be absorbed on cloth or paper and allowed to evaporate in a safe place such as a chemical fume hood. Ethylene oxide should not be allowed to enter a confined space such as a sewer. Workers should not enter confined spaces where ethylene oxide has been stored without following proper operating procedures designed to ensure that toxic or explosive concentrations are not present. Whenever possible, ethylene oxide should be stored and used in closed systems or with adequate local exhaust ventilation.

All substances having carcinogenic properties, such as ethylene oxide and vinylcyclohexene dioxide, must be handled with extreme care to avoid contact with the workers’ skin or being inhaled during both production and use. Prevention of contact is also promoted by designing the work premises and process plant so as to preclude any leakage of the product (application of a slight negative pressure, hermetically sealed process and so on). Precautions are discussed more fully elsewhere in this Encyclopaedia.

Epoxy compounds tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3- Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 00:34

Cyano Compounds

This class of compounds is characterized by the presence of a C=N (cyano) group and includes the cyanides and nitriles (R–C=N) as well as related chemicals such as cyanogens, isocyanates and cyanamides. They primarily owe their toxicity to the cyanide ion, which is capable of inhibiting many enzymes, especially cytochrome oxidase, when released in the body. Death, which may be more or less rapid depending on the rate at which the cyanide ion is released, results from chemical asphyxia at the cellular level.

Inorganic Cyanides

Inorganic cyanides are readily hydrolyzed by water and decomposed by carbon dioxide and mineral acids to form hydrogen cyanide, which can also be produced by certain naturally occurring bacteria. Hydrogen cyanide is evolved in coke and steel-making, and can be generated in fires where polyurethane foam is incinerated (e.g., furniture, partitions and so on). It can be generated accidentally by the action of acids on cyanide-containing wastes (lactonitrile evolves hydrocyanic acid when in contact with an alkali, for example.), and intentionally in gas chambers for capital punishment, where cyanide pellets are dropped into bowls of acid to create a lethal atmosphere.

Nitriles

Nitriles (also called organic cyanides) are organic compounds which contain a cyano group
(–C=N) as the characteristic functional group and have the generic formula RCN. They may be regarded as hydrocarbon derivatives wherein three hydrogen atoms attached to a primary carbon are replaced by a nitrilo group, or as derivatives of carboxylic acids (R—COOH) in which the oxo and hydroxyl radicals are replaced by a nitrilo group (R—C=N). Upon hydrolysis, they yield an acid which contains the same number of carbon atoms and which, therefore, is usually named by analogy with the acid rather than as a derivative of hydrogen cyanide. They are very dangerous when heated to decomposition because of the release of hydrogen cyanide.

Saturated aliphatic nitriles up to C14 are liquids having a rather pleasant odour like the ethers. Nitriles of C14 and higher are odourless solids and generally colourless. Most nitriles will boil without decomposition at temperatures lower than those for the corresponding acids. They are extremely reactive compounds and are used extensively as intermediates in organic synthesis. They are widely used starting materials in the synthesis of various fatty acids, pharmaceuticals, vitamins, synthetic resins, plastics and dyes.

Uses

The inorganic cyano compounds have varied uses in the metal, chemical, plastics and rubber industries. They are utilized as chemical intermediates, pesticides, metal cleaners, and as agents for extracting gold and silver from ores.

Acryonitrile (vinyl cyanide, cyanoethylene, propene nitrile), a flammable and explosive colourless liquid, is found in surface coatings and adhesives and is used as a chemical intermediate in the synthesis of antioxidants, pharmaceuticals, pesticides, dyes and surface-active agents.

Calcium cyanamide (nitrolim, calcium carbimide, cyanamide) is a blackish-grey, shiny powder used in agriculture as a fertilizer, herbicide, pesticide and a defoliant for cotton plants. It is also used in steel hardening and as a desulphurizer in the iron and steel industry. In industry, calcium cyanamide is used for the manufacture of calcium cyanide and dicyandiamide, the raw material for melamine.

Cyanogen, cyanogen bromide and cyanogen chloride are used in organic syntheses. Cyanogen is also a fumigant and a fuel gas for welding and cutting heat-resistant metals. It is a rocket or missile propellant in mixtures with ozone or fluorine; and it may also be present in blast furnace emissions. Cyanogen bromide is utilized in textile treatment, as a fumigant and pesticide, and in gold extraction processes. Cyanogen chloride serves as a warning agent in fumigant gases.

Hydrogen cyanide finds use in the manufacture of synthetic fibres and plastics, in metal polishes, electroplating solutions, metallurgical and photographic processes, and in the production of cyanide salts. Sodium cyanide and potassium cyanide are used in electroplating, steel hardening, extraction of gold and silver from ores, and in the manufacture of dyes and pigments. In addition, sodium cyanide functions as a depressant in the froth flotation separation of ores.

Potassium ferricyanide (red prussiate of potash) is used in photography and in blueprints, metal tempering, electroplating and pigments. Potassium ferrocyanide (yellow prussiate of potash) is used in the tempering of steel and in process engraving. It is employed in the manufacture of pigments and as a chemical reagent.

Calcium cyanide, malononitrile, acetone cyanohydrin (2-hydroxy-2-methylproprionitrile), cyanamide and acrylonitrile are other useful compounds in the metal, plastics, rubber and chemical industries. Calcium cyanide and malononitrile are leaching agents for gold. In addition, calcium cyanide is used as a fumigant, a pesticide, a stabilizer for cement, and in the manufacture of stainless steel. Acetone cyanohydrin is a complexing agent for metal refining and separation, and cyanamide is used in metal cleaners, the refining of ores and the production of synthetic rubber. Ammonium thiocyanate is used in the match and photography industries and for double-dyeing fabrics and improving the strength of silks weighted with tin salts. It is a stabilizer for glues, a tracer in oil fields, and an ingredient in pesticides and liquid rocket propellants. Potassium cyanate serves as a chemical intermediate and as a weed killer.

Some of the more important organic nitriles in industrial use include acryonitrile (vinyl cyanamide, cyanethylene, propene nitrile), acetonitrile, (methyl cyanamide, ethanenitrile, cyanomethane), ethylene cyanohydrin, proprionitrile (ethyl cyanide), lactonitrile, glycolonitrile (formaldehyde cyanohydrin, hydroxyacetonitrile, hydroxymethylcyanide, methylene cyanohydrin), 2-methyl-lactonitrile, and adiponitrile.

Hazards

Cyanide compounds are toxic to the extent that they release the cyanide ion. Acute exposure can cause death by asphyxia, as the result of exposure to lethal concentrations of hydrogen cyanide (HCN) whether by inhalation, ingestion or percutaneous absorption; in the last case, however, the dose required is higher. Chronic exposure to cyanides at levels too low to produce such serious symptoms may cause a variety of problems. Dermatitis, often accompanied by itching, an erythematous rash and papules, has been a problem for workers in the electroplating industry. Severe irritation of the nose may lead to obstruction, bleeding, sloughs and, in some cases, perforation of the septum. Among fumigators, mild cyanide poisoning has been recognized as the cause of symptoms of oxygen starvation, headache, rapid heart rate, and nausea, all of which were completely reversed when the exposure ceased.

Chronic systemic cyanide poisoning may occur, but is rarely recognized because of the gradual onset of the disability, and symptoms which are consistent with other diagnoses. It has been suggested that excessive thiocyanate in extracellular fluids might explain chronic illness due to cyanide, since the symptoms reported are similar to those found when thiocyanate is used as a drug. Symptoms of chronic disease have been reported in electroplaters and silver polishers after several years of exposure. The most prominent were motor weakness of arms and legs, headaches and thyroid diseases; these findings have also been reported as complications of thiocyanate therapy.

Toxicity

Cyanides

The cyanide ion of soluble cyanide compounds is rapidly absorbed from all routes of entry—inhalation, ingestion and percutaneous. Its toxic properties result from its ability to form complexes with heavy metal ions which inhibit the enzymes required for cellular respiration, primarily cytochrome oxidase. This prevents the uptake of oxygen by the tissues, causing death by asphyxia. The blood retains its oxygen, producing the characteristic cherry-red colour of the victims of acute cyanide poisoning. Cyanide ions combine with the approximately 2% of methaemoglobin normally present—a fact that has helped to develop the treatment of cyanide poisoning.

If the initial dose is not fatal, part of the cyanide dose is exhaled unchanged, while rhodanase, an enzyme widely distributed in the body, converts the remainder to the much less harmful thiocyanate, which remains in extracellular body fluids until it is excreted in the urine. Urinary levels of thiocyanate have been used to measure the extent of the intoxication, but they are non-specific and are elevated in smokers. There may be an effect on thyroid function due to the affinity of thiocyanate ion for iodine.

There are variations in the biological effects of the compounds in this group. At low concentrations, hydrogen cyanide (hydrocyanic acid, prussic acid) and the halogenated cyanide compounds (i.e., cyanogen chloride and bromide) in vapour form produce irritation of the eyes and the respiratory tract (the respiratory effects, including pulmonary oedema, may be delayed). Systemic effects include weakness, headaches, confusion, nausea and vomiting. In mild cases, the blood pressure remains normal despite increase in the pulse rate. The respiratory rate varies with the intensity of exposure—rapid with mild exposure, or slow and gasping with severe exposure.

Nitriles

The toxicity of nitriles varies greatly with their molecular structure, ranging from comparatively non-toxic compounds (e.g., the saturated fatty acid nitriles) to highly toxic materials, such as α-aminonitriles and α-cyanohydrins, which are considered to be as toxic as hydrocyanic acid itself. The halogenated nitriles are highly toxic and irritant, and cause considerable lacrimation. Nitriles such as acrylonitrile, propionitrile and fumaronitrile are toxic and may cause severe and painful dermatitis in exposed skin.

Exposure to toxic nitriles may rapidly cause death by asphyxiation similar to that resulting from exposure to hydrogen cyanide. Individuals who survived exposure to high concentrations of nitriles were said to have no evidence of residual physiological effects after the recovery from the acute episode; this has led to the opinion that the person either succumbs to the nitrile exposure or recovers completely.

Medical surveillance should include pre-employment and periodic examinations focused on skin disorders and the cardiovascular, pulmonary and central nervous systems. A history of fainting spells or convulsive disorders might present an added risk for nitrile workers.

All nitriles should be handled under carefully controlled conditions and only by personnel having a thorough understanding and knowledge of safe handling techniques. Leather should not be used for protective garments, gloves and footwear, since it may be penetrated by acryonitrile and other similar compounds; rubber protective equipment should be washed and inspected frequently to detect swelling and softening. The eyes should be protected, proper respirators worn, and all splashes immediately and thoroughly washed away.

Acrylonitrile. Acrylonitrile is a chemical asphyxiant like hydrogen cyanide. It is also an irritant, affecting the skin and mucous membranes; it may cause severe corneal damage in the eye if not rapidly washed away by copious irrigation. IARC has classified acrylonitrile as a Group 2A carcinogen: the agent is probably carcinogenic to humans. The classification is based on limited evidence of carcinogenicity in humans and sufficient evidence of carcinogenicity in animals.

Acrylonitrile may be absorbed by inhalation or through the skin. In gradual exposures, victims may have significant levels of cyanide in the blood before symptoms appear. They derive from tissue anoxia and include, roughly in order of onset, limb weakness, dyspnoea, burning sensation in the throat, dizziness and impaired judgement, cyanosis and nausea. In the later stages, collapse, irregular breathing or convulsions and cardiac arrest may occur without warning. Some patients appear hysterical or may even be violent; any such deviations from normal behaviour should suggest acryonitrile poisoning.

Repeated or prolonged skin contact with acrylonitrile may produce irritation after hours of no apparent effect. Since acrylonitrile is readily absorbed into leather or clothing, blistering may appear unless the contaminated articles are removed promptly and the underlying skin washed. Rubber clothing should be inspected and washed frequently because it will soften and swell.

An important hazard is fire and explosion. The low flashpoint indicates that sufficient vapour is evolved at normal temperatures to form a flammable mixture with air. Acrylonitrile has the ability to polymerize spontaneously under the action of light or heat, which may lead to explosion even when it is kept in closed containers. It must therefore never be stored uninhibited. The danger of fire and explosion is intensified by the lethal nature of the fumes and vapours evolved, such as ammonia and hydrogen cyanide.

Calcium cyanamide. Calcium cyanamide is encountered chiefly as a dust. When inhaled, it will cause rhinitis, pharyngitis, laryngitis and bronchitis. Perforation of the nasal septum has been reported after long exposure. In the eyes, it may cause conjunctivitis, keratitis and corneal ulceration. It may cause an itchy dermatitis which, after a time, may present slowly-healing ulcerations on the palms of the hand and between the fingers. Skin sensitization may occur.

Its most notable systemic effect is a characteristic vasomotor reaction featuring diffuse erythema of the body, face and arms which may be accompanied by fatigue, nausea, vomiting, diarrhoea, dizziness and sensations of cold. In severe cases, circulatory collapse may ensue. This vasomotor reaction may be triggered or exaggerated by consumption of alcohol.

In addition to adequate exhaust ventilation and personal protective equipment, a waterproof barrier cream may provide added protection for face and exposed skin. Good personal hygiene, including showers and changes of clothing after each shift, is important.

Cyanates. Some of the more important cyanates in industrial use include sodium cyanate, potassium cyanate, ammonium cyanate, lead cyanate and silver cyanate. Cyanates of such elements as barium, boron, cadmium, cobalt, copper, silicon, sulphur and thallium may be prepared by reactions between solutions of a cyanate and the corresponding salt of the metal. They are dangerous because they release hydrogen cyanide when heated to decomposition or when in contact with acid or acid fumes. Personnel handling these materials should be provided with respiratory and skin protection.

Sodium cyanate is used in organic synthesis, the heat treatment of steel, and as an intermediate in the manufacture of pharmaceuticals. It is considered to be moderately toxic, and workers should be protected against dust inhalation and skin contamination.

Cyanate compounds vary in toxicity; therefore, they should be handled under controlled conditions, taking standard precautions to protect personnel against exposure. When heated to decomposition or when placed in contact with acid or acid fumes, the cyanates emit highly toxic fumes. Adequate ventilation must be provided, and air quality at the worksite should be closely monitored. Personnel should not inhale contaminated air nor allow skin contact with these materials. Good personal hygiene is essential for those working in areas where such compounds are handled.

Safety and Health Measures

Scrupulous attention to proper ventilation is necessary. Complete enclosure of the process is recommended, with supplementary exhaust ventilation available. Warning signs should be posted near entrances to areas in which hydrogen cyanide may be released into the air. All shipping and storage containers for hydrogen cyanide or cyanide salts should bear a warning label that included instructions for first aid; they should be in a well-ventilated area and handled with great care.

Those working with cyanide salts should fully understand the hazard. They should be trained to recognize the characteristic odour of hydrogen cyanide and to evacuate the work area immediately if it is detected. Workers entering a contaminated area must be supplied with air-supplied or self-contained respirators with canisters specific for cyanides, goggles if full-face masks are not worn, and impervious protective clothing.

For those who work with acrylonitrile, the usual precautions for carcinogens and for highly flammable liquids are necessary. Steps must be taken to eliminate the risk of ignition from sources such as electrical equipment, static electricity and friction. Because of the toxic, as well as the flammable, nature of the vapour, its escape into the worksite air must be prevented by enclosure of the process and exhaust ventilation. Continuous monitoring of the workplace air is necessary to ensure that these engineering controls remain effective. Personal respiratory protection, preferably of the positive pressure type, and impermeable protective clothing are necessary when there is a possibility of exposure, as from a normal but non-routine operation such as a pump replacement. Leather should not be used for protective clothing since it is readily penetrated by acrylonitrile; rubber and other types of clothing should be inspected and washed frequently.

Acrylonitrile workers should be educated about the chemical’s dangers and trained in rescue, decontamination, life-support procedures and the use of amyl nitrate. Skilled medical attention is required in emergencies; principal requirements are an alarm system and plant personnel trained to support the activities of the health professionals. Supplies of specific antidotes should be available on site and at adjacent hospital centres.

Medical surveillance of workers potentially exposed to cyanides should focus on the respiratory, cardiovascular and central nervous systems; liver, kidney and thyroid function; condition of the skin; and a history of fainting or dizzy spells. Workers with chronic diseases of the kidneys, respiratory tract, skin or thyroid are at greater risk of developing toxic cyanide effects than healthy workers.

Medical control requires training in artificial resuscitation and the use of drugs prescribed for emergency treatment of acute poisoning (e.g., inhalations of amyl nitrite). As soon as possible, contaminated clothing, gloves and footwear should be removed and the skin washed to prevent continuing absorption. First-aid kits with drugs and syringes should be placed appropriately at hand and checked frequently.

Unfortunately, some widely distributed handbooks suggest that methylene blue is useful in cyanide poisoning because, at certain concentrations, it forms methaemoglobin, which, because of its affinity for the cyanide ion, might reduce the toxic effect. The use of methylene blue is not recommended since at other concentrations it has the reverse effect of converting methaemoglobin to haemoglobin, and analyses to verify that its concentration is appropriate are not feasible under the conditions created by the cyanide emergency.

Treatment

Individuals exposed to toxic levels of nitriles should be immediately removed to a safe area and given amyl nitrite by inhalation. Any indications of respiratory problems would indicate oxygen inhalation and, if necessary, cardiopulmonary resuscitation. Contaminated clothing should be removed and the areas of skin copiously washed. Extended flushing of the eyes with neutral solutions or water is advised if there is lacrimation or any evidence of conjunctival irritation. Properly trained physicians, nurses and emergency medical technicians should be summoned to the scene promptly to administer definitive treatment and keep the victim under close observation until recovery is complete.

Cyano compounds tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Wednesday, 03 August 2011 00:27

Boranes

Uses

Boron and boranes have varied functions in the electronics, metalworking, chemical, pulp and paper, ceramics, textile and construction industries. In the electronics industry, boron, boron tribromide and boron trichloride are used as semiconductors. Boron is an igniter in radio tubes and a degasifying agent in metallurgy. It is also used in pyrotechnic flares. Diborane, pentaborane and decaborane are utilized in high-energy fuel. Boron trichloride, diborane and decaborane are rocket propellants, and triethylboron and boron serve as igniters for jet and rocket engines. 10Boron is employed in the nuclear industry as a constituent of neutron-shielding material in reactors.

In the metalworking industry, many of the boranes are used in welding and brazing. Other compounds are employed as flame retardants and as bleaching agents in the textile, paper and pulp, and paint and varnish industries. Boron oxide is a fire-resistant additive in paints and varnishes, while sodium tetraborate, borax and trimethyl borate are fireproofing agents for textile goods. Both borax and sodium tetraborate are used for the fireproofing and artificial aging of wood. In the construction industries, they are components of fibreglass insulation. Sodium tetraborate also serves as an algicide in industrial water and as an agent in the tanning industry for curing and preserving skins. Borax is a germicide in cleaning products, a corrosion inhibitor in antifreeze, and a powdered insecticide for crack and crevice treatment of food-handling areas. Decaborane is a rayon delustrant and a mothproofing agent in the textile industry, and sodium borohydride is a bleaching agent for wood pulp.

In the ceramics industry, boron oxide and borax are found in glazes, and sodium tetraborate is a component of porcelain enamels and glazes. Sodium perborate is employed for bleaching textile goods and for electroplating. It is used in soaps, deodorants, detergents, mouthwash and vat dyes. Boron trifluoride is used in food packaging, electronics, and in the nuclear industry’s breeder reactors.

Health Hazards

Boron is a naturally occurring substance that is commonly found in food and drinking water. In trace amounts it is essential to the growth of plants and certain types of algae. Although it is also found in human tissue, its role is unknown. Boron is generally regarded as safe (GRAS) for use as an indirect food additive (e.g., in packaging), but compounds containing boron can be highly toxic. Boron is present in a number of industrially useful compounds, including borates, boranes and boron halides.

Boron toxicity in humans is seen most commonly following chronic use of medicines containing boric acid and in cases of accidental ingestion, especially among young children. Occupational toxicity usually results from exposure of the respiratory system or open skin wounds to dusts, gases or vapours of boron compounds.

Acute irritation of eyes, skin and the respiratory tract can follow contact with almost any of these materials in usual concentrations. Absorption can affect the blood, respiratory tract, digestive tract, kidneys, liver and central nervous system; in severe cases, it can result in death.

Boric acid is the most common of the borates, which are compounds of boron, oxygen and other elements. Acute exposure to boric acid in liquid or solid forms can cause irritation, the severity of which is determined by the concentration and duration of exposure. Inhalation of borate dusts or mists can directly irritate the skin, eyes and respiratory system.

Symptoms of this irritation include eye discomfort, dry mouth, sore throat and productive cough. Workers usually report these symptoms after acute boric acid exposures over
10 mg/m3; however, chronic exposures of less than half this can also cause irritant symptoms.

Workers exposed to borax (sodium borate) dust have reported chronic productive cough, and, in those who have experienced long exposures, obstructive abnormalities have been detected, though it is unclear whether these are related to exposure.

Borates are readily absorbed through open skin wounds and from the respiratory and digestive tracts. After absorption borates exert predominant actions upon the skin, central nervous system and digestive tract. Symptoms generally develop rapidly, but may take hours to evolve following skin exposures. Following absorption, the skin or mucous membranes may develop abnormal redness (erythema), or surface tissue may be shed. Chronic exposure may cause eczema, patchy hair loss and swelling around the eyes. These dermatologic effects may take days to develop after exposure. The individual may experience abdominal pain, nausea, vomiting and diarrhoea. Vomitus and diarrhoea may be blue-green in colour and may contain blood. Headache, excitement or depression, seizures, lethargy and coma may develop.

In instances of acute poisoning, anaemia, acidosis and dehydration develop, accompanied by rapid, weak pulse and low blood pressure. These effects may be followed by irregular heart rhythm, shock, kidney failure and, in rare cases, liver damage. Victims appear pale, sweaty and acutely ill. Most of these severe findings have been present just before death from acute borate toxicity. However, when victims are diagnosed and treated in time, the effects usually are reversible.

The reproductive effects of borates are still unclear. Boric acid exposure inhibited sperm motility in rats and, at higher levels, led to testicular atrophy. Animal and tissue studies of genotoxicity have been negative, but infertility has been demonstrated in both males and females after chronic boric acid feedings. Offspring have shown delayed and abnormal development including abnormal rib development. In humans, there is only suggestive evidence of decreased fertility among the few workers who have been evaluated in uncontrolled studies.

Boron trihalides—boron trifluoride, boron chloride and boron bromide—can react violently with water, liberating hydrogen halides such as hydrochloric and hydrofluoric acids. Boron trifluoride is a severe irritant of the lungs, eyes and skin. Animals studied after lethal exposures showed kidney failure and kidney tubule damage, pulmonary irritation and pneumonia. Examinations of a small number of exposed workers showed some decreases in pulmonary function, but it was unclear whether these were related to exposure.

Boranes (boron hydrides)—diborane, pentaborane and decaborane—are extremely reactive compounds which can explode on contact with oxygen or oxidizing agents. As a group they are severe irritants which can quickly cause chemical pneumonia, pulmonary oedema and other respiratory injuries. In addition, boranes have been reported to cause seizures and neurological damage with long-lasting neurological deficits and psychological symptoms. These compounds must be handled with extreme caution.

There is no evidence of boron or the borates causing cancer in chronic experiments with animals or in studies of exposed humans.

Boranes tables

Table 1 - Chemical information.

Table 2 - Health hazards.

Table 3 - Physical and chemical hazards.

Table 4 - Physical and chemical properties.

 

Back

Page 21 of 122

" DISCLAIMER: The ILO does not take responsibility for content presented on this web portal that is presented in any language other than English, which is the language used for the initial production and peer-review of original content. Certain statistics have not been updated since the production of the 4th edition of the Encyclopaedia (1998)."

Contents

Health Care Facilities and Services References

Abdo, R and H Chriske. 1990. HAV-Infektionsrisiken im Krankenhaus, Altenheim und Kindertagesstätten. In Arbeitsmedizin im Gesundheitsdienst, Band 5, edited by F Hofmann and U Stössel. Stuttgart: Gentner Verlag.

Acton, W. 1848. On the advantages of caouchoue and gutta-percha in protecting the skin against the contagion of animal poisons. Lancet 12:588.

Ahlin, J. 1992. Interdisciplinary case studies in offices in Sweden. In Corporate Space and Architecture. Vol. 2. Paris: Ministére de l’équipment et du logement.

Akinori, H and O Hiroshi. 1985. Analysis of fatigue and health conditions among hospital nurses. J Science of Labour 61:517-578.

Allmeers, H, B Kirchner, H Huber, Z Chen, JW Walter, and X Baur. 1996. The latency period between exposure and the symptoms in allergy to natural latex: Suggestions for prevention. Dtsh Med Wochenschr 121 (25/26):823-828.

Alter, MJ. 1986. Susceptibility to varicella zoster virus among adults at high risk for exposure. Infec Contr Hosp Epid 7:448-451.

—. 1993. The detection, transmission, and outcome of hepatitis C infection. Infect Agents Dis 2:155-166.

Alter, MJ, HS Margolis, K Krawczynski, FN Judson, A Mares, WJ Alexander, PY Hu, JK Miller, MA Gerber, and RE Sampliner. 1992. The natural history of community-acquired hepatitis C in the United States. New Engl J Med 327:1899-1905.

American Conference of Governmental Industrial Hygienists (ACGIH). 1991. Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th edition. Cincinnati, OH: ACGIH.

—. 1994. TLVs: Threshold Limit Values and Biological Exposure Indices for 1994-1995. Cincinnati, OH: ACGIH.

American Hospital Association (AHA). 1992. Implementing Safer Needle Practice. Chicago, IL: AHA.

American Institute of Architects. 1984. Determining Hospital Space Requirements. Washington, DC: American Institute of Architects Press.

American Institute of Architects Committee on Architecture for Health. 1987. Guidelines for Construction and Equipment of Hospital and Medical Facilities. Washington, DC: American Institute of Acrchitects Press.

American Society of Heating, Refrigerating and Air-conditioning Engineers (ASHRAE). 1987. Health facilities. In ASHRAE Handbook: Heating, Ventilating and Air-conditioning Systems and Applications. Atlanta, GA: ASHRAE.

Anon. 1996. New drugs for HIV infection. Medical Letter of Drugs and Therapeutics 38:37.

Axelsson, G, R Rylander, and I Molin. 1989. Outcome of pregnancy in relation to irregular and inconvenient work schedules. Brit J Ind Med 46:393-398.

Beatty, J SK Ahern, and R Katz. 1977. Sleep deprivation and the vigilance of anesthesiologists during simulated surgery. In Vigilance, edited by RR Mackie. New York: Plenum Press.

Beck-Friis, B, P Strang, and PO Sjöden. 1991. Work stress and job satisfaction in hospital-based home care. Journal of Palliative Care 7(3):15-21.

Benenson, AS (ed.). 1990. Control of Communicable Disease in Man, 15th edition. Washington, DC: American Public Health Association.

Bertold, H, F Hofmann, M Michaelis, D Neumann-Haefelin, G Steinert, and J Wölfle. 1994. Hepatitis C—Risiko für Beschäftigte im Gesundheitsdienst? In Arbeitsmedizin im Gesundheitsdienst, Band 7, edited by F Hofmann, G Reschauer, and U Stössel. Stuttgart: Gentner Verlag.

Bertram, DA. 1988. Characteristics of shifts and second-year resident performance in an emergency department. NY State J Med 88:10-14.

Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW). 1994. Geschäftsbericht.

Bissel, L and R Jones. 1975. Disabled doctors ignored by peers. Presented at the American Medical Association Conference on the Imparied Physician, 11 April, San Francisco, CA.

Bitker, TE. 1976. Reaching out to the depressed physician. JAMA 236(15):1713-1716.

Blanchard, M, MM Cantel, M Faivre, J Girot, JP Ramette, D Thely, and M Estryn-Béhar. 1992. Incidence des rythmes biologiques sur le travail de nuit. In Ergonomie à l’hôpital, edited by M Estryn-Béhar, C Gadbois, and M Pottier. Toulouse: Edition Octares.

Blanpain, C and M Estryn-Béhar. 1990. Measures d’ambiance physique dans dix services hospitaliers. Performances 45:18-33.

Blaycock, B. 1995. Latex allergies: Overview, prevention and implications for nursing care. Ostomy Wound Manage 41(5):10-12,14-15.

Blazer, MJ, FJ Hickman, JJ Farmer, and DJ Brenner. 1980. Salmonella typhi: The laboratory as a reservoir of infection. Journal of Infectious Diseases 142:934-938.

Blow, RJ and MIV Jayson. 1988. Back pain. In Fitness for Work: The Medical Approach, edited by FC Edwards, RL McCallum, and PJ Taylor. Oxford: Oxford University Press.

Boehm, G and E Bollinger. 1990. Significance of environmental factors on the tolerated enteral feeding volumes for patients in neonatal intensive care units. Kinderarzliche Praxis 58(6):275-279.

Bongers, P, RD Winter, MAJ Kompier, and VV Hildebrandt. 1992. Psychosocial Factors at Work and Musculoskeletal Diseases. Review of the literature. Leiden, Netherlands: TNO.

Bouhnik, C, M Estryn-Béhar, B Kapitaniak, M Rocher, and P Pereau. 1989. Le roulage dans les établissements de soins. Document pour le médecin du travail. INRS 39:243-252.

Boulard, R. 1993. Les indices de santé mentale du personnel infirmier: l’impact de la charge de travail, de l’autonomie et du soutien social. In La psychologie du travail à l’aube du XXI° siècle. Actes du 7° Congrès de psychologie du travail de langue française. Issy-les-Moulineaux: Editions EAP.

Breakwell, GM. 1989. Facing Physical Violence. London: British Psychological Society.

Bruce, DL and MJ Bach. 1976. Effects of Trace Concentrations of Anesthetic Gases on Behavioral Performance of Operating Room Personnel. DHEW (NIOSH) Publication No. 76-169. Cincinnati, OH: NIOSH.

Bruce, DL, KA Eide, HW Linde, and JE Eckenhoff. 1968. Causes of death among anesthesiologists: A 20 years survey. Anesthesiology 29:565-569.

Bruce, DL, KA Eide, NJ Smith, F Seltzer, and MH Dykes. 1974. A prospective survey of anesthesiologists’ mortality, 1967-1974. Anesthesiology 41:71-74.

Burhill, D, DA Enarson, EA Allen, and S Grzybowski. 1985. Tuberculosis in female nurses in British Columbia. Can Med Assoc J 132:137.

Burke, FJ, MA Wilson, and JF McCord. 1995. Allergy to latex gloves in clinical practice: Case reports. Quintessence Int 26(12):859-863.

Buring, JE, CH Hennekens, SL Mayrent, B Rosner, ER Greenberg, and T Colton. 1985. Health experiences of operating room personnel. Anesthesiology 62: 325-330.

Burton, R. 1990. St. Mary’s Hospital, Isle of Wight: A suitable background for caring. Brit Med J 301:1423-1425.

Büssing, A. 1993. Stress and burnout in nursing: Studies in different work structures and work schedules. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Cabal, C, D Faucon, H Delbart, F Cabal, and G Malot. 1986. Construction d’une blanchisserie industrielle aux CHU de Saint-Etienne. Arch Mal Prof 48(5):393-394.

Callan, JR, RT Kelly, ML Quinn, JW Gwynne, RA Moore, FA Muckler, J Kasumovic, WM Saunders, RP Lepage, E Chin, I Schoenfeld, and DI Serig. 1995. Human Factors Evaluation of Remote Afterloading Brachytherapy. NUREG/CR-6125. Vol. 1. Washington, DC: Nuclear Regulatory Commission

Cammock, R. 1981. Primary Health Care Buildings: Briefing and Design Guide for Architects and Their Clients. London: Architectural Press.

Cardo, D, P Srivastava, C Ciesielski, R Marcus, P McKibben, D Culver, and D Bell. 1995. Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood (abstract). Infect Control Hosp Epidemiol 16 suppl:20.

Carillo, T, C Blanco, J Quiralte, R Castillo, M Cuevas, and F Rodriguez de Castro. 1995. Prevalence of latex allergy among greenhouse workers. J Allergy Clin Immunol 96(5/1):699-701.

Catananti, C and A Cambieri. 1990. Igiene e Tecnica Ospedaliera (Hospital Hygiene and Organization). Roma: II Pensiero Scientifico Editore.

Catananti, C, G Damiani, G Capelli, and G Manara. 1993. Building design and selection of materials and furnishings in the hospital: A review of international guidelines. In Indoor Air ’93, Proceedings of the 6th International Conference on Indoor Air Quality and Climate 2:641-646.

Catananti, C, G Capelli, G Damiani, M Volpe, and GC Vanini. 1994. Multiple criteria evaluation in planning selection of materials for health care facilities. Preliminary identification of criteria and variables. In Healthy Buildings ’94, Proceedings of the 3rd International Conference 1:103-108.

Cats-Baril, WL and JW Frymoyer. 1991. The economics of spinal disorders. In The Adult Spine, edited by JW Frymoyer. New York: Raven Press.

Centers for Disease Control (CDC). 1982. Acquired immunodeficiency syndrome (AIDS): Precautions for clinical laboratory staffs. Morb Mortal Weekly Rep 31:577-580.

—. 1983. Acquired immunodeficiency syndrome (AIDS): Precautions for health-care workers and allied professionals. Morb Mortal Weekly Rep 32:450-451.

—. 1987a. Human immunodeficiency virus infection in health-care workers exposed to blood of infected patients. Morb Mortal Weekly Rep 36:285-289.

—. 1987b. Recommendations for prevention of HIV transmission in health-care settings. Morb Mortal Weekly Rep 36 suppl 2:3S-18S.

—. 1988a. Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. Morb Mortal Weekly Rep 37:377-382,387-388.

—. 1988b. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Morb Mortal Weekly Rep 37 suppl 6:1-37.

—. 1989. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Morb Mortal Weekly Rep 38 suppl 6.

—. 1990. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding post-exposure use. Morb Mortal Weekly Rep 39 (No. RR-1).

—. 1991a. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). Morb Mortal Weekly Rep 40 (No. RR-13).

—. 1991b. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Morb Mortal Weekly Rep 40 (No. RR-8).

—. 1993a. Recommended infection-control practices in dentistry. Morb Mortal Weekly Rep 42 (No. RR-8):1-12.

—. 1993b. Biosafety in Microbial and Biomedical Laboratories, 3rd edition. DHHS (CDC) Publication No. 93-8395. Atlanta, GA: CDC.

—. 1994a. HIV/AIDS Surveillance Report. Vol. 5(4). Atlanta, GA: CDC.

—. 1994b. HIV/AIDS Prevention Newsletter. Vol. 5(4). Atlanta, GA: CDC.

—. 1994c. Human immunodeficiency virus in household settings—United States. Morb Mortal Weekly Rep 43:347-356.

—. 1994d. HIV/AIDS Surveillance Report. Vol. 6(1). Atlanta, GA: CDC.

—. 1994e. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morb Mortal Weekly Rep 43 (No. RR-13):5-50.

—. 1995. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood—France, United Kingdom, and United States. Morb Mortal Weekly Rep 44:929-933.

—. 1996a. HIV/AIDS Surveillance Report. Vol 8(2). Atlanta, GA: CDC.

—. 1996b. Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morb Mortal Weekly Rep 45:468-472.

Charney, W (ed.). 1994. Essentials of Modern Hospital Safety. Boca Raton, FL: Lewis Publishers.

Chou, T, D Weil, and P Arnmow. 1986. Prevalence of measles antibodies in hospital personnel. Infec Contr Hosp Epid 7:309-311.

Chriske, H and A Rossa. 1991. Hepatitis-C-Infektionsgefährdung des medizinischen Personals. In Arbeitsmedizin im Gesundheitsdienst, Band 5, edited by F Hofmann and U Stössel. Stuttgart: Gentner Verlag.

Clark, DC, E Salazar-Gruesco, P Grabler, J Fawcett. 1984. Predictors of depression during the first 6 months of internship. Am J Psychiatry 141:1095-1098.

Clemens, R, F Hofmann, H Berthold, and G Steinert. 1992. Prävalenz von Hepatitis, A, B und C bei Bewohern einer Einrichtung für geistig Behinderte. Sozialpädiatrie 14:357-364.

Cohen, EN. 1980. Anasthetic Exposure in the Workplace. Littleton, MA: PSG Publishing Co.

Cohen, EN, JW Bellville, and BW Brown, Jr. 1971. Anesthesia, pregnancy and miscarriage: A study of operating room nurses and anesthetists. Anesthesiology 35:343-347.

—. 1974. Occupational disease among operating room personnel: A national study. Anesthesiology 41:321-340.

—. 1975. A survey of anethestic health hazards among dentists. J Am Dent Assoc 90:1291-1296.

Commission of the European Communities. 1990. Recommendation of the Commission February 21, 1990, about Protection of People against Exposure to Radon in Indoor Environments. 90/143/Euratom (Italian Translation).

Cooper, JB. 1984. Toward prevention of anesthesic mishaps. International Anesthesiology Clinics 22:167-183.

Cooper, JB, RS Newbower, and RJ Kitz. 1984. An analysis of major errors and equipment failures in anesthesia management: Considerations for prevention and detection. Anesthesiology 60(1):34-42.

Costa, G, R Trinco, and G Schallenberg. 1992. Problems of thermal comfort in an operating room equipped with laminar air flow system In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar M, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Cristofari, M-F, M Estryn-Béhar, M Kaminski, and E Peigné. 1989. Le travail des femmes à l’hôpital. Informations Hospitalières 22/23:48-62.

Council of the European Communities. 1988. Directive December 21, 1988, to Draw Near the Laws of Member Countries about Building Products. 89/106/EEC (Italian translation).

de Chambost, M. 1994. Alarmes sonnantes, soignantes trébuchantes. Objectif soins 26:63-68.

de Keyser, V and AS Nyssen. 1993. Les erreurs humaines en anesthésies. Le Travail humain 56(2/3):243-266.

Decree of the President of Ministers Council. 1986. Directive to the Regions about Private Health Care Facilities Requirements. 27 June.

Dehlin, O, S Berg, GBS Andersson, and G Grimby. 1981. Effect of physical training and ergonomic counselling on the psychosocial perception of work and on the subjective assesment of low-back insuffuciency. Scand J Rehab 13:1-9.

Delaporte, MF, M Estryn-Béhar, G Brucker, E Peigne, and A Pelletier. 1990. Pathologie dermatologique et exercice professionnel en milieu hospitalier. Arch Mal Prof 51(2):83-88.

Denisco, RA, JN Drummond, and JS Gravenstein. 1987. The effect of fatigue on the performance of a simulated anesthetic monitoring task. J Clin Monit 3:22-24.

Devienne, A, D Léger, M Paillard, A Dômont. 1995. Troubles du sommeil et de la vigilance chez des généralistes de garde en région parisienne. Arch Mal Prof 56(5):407-409.

Donovan, R, PA Kurzman, and C Rotman. 1993. Improving the lives of home care workers: A partnership of social work and labor. Soc Work 38(5):579-585..

Edling, C. 1980. Anesthetic gases as an occupational hazard. A review. Scand J Work Environ Health 6:85-93.

Ehrengut, W and T Klett. 1981. Rötelnimmunstatus von Schwesternschülerinnen in Hamberger Krankenhäusern im Jahre 1979. Monatsschrift Kinderheilkdunde 129:464-466.

Elias, J, D Wylie, A Yassi, and N Tran. 1993. Eliminating worker exposure to ethylene oxide from hospital sterilizers: An evaluation of cost and effectiveness of an isolation system. Appl Occup Environ Hyg 8(8):687-692.

Engels, J, TH Senden, and K Hertog. 1993. Working postures of nurses in nursing homes. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Englade J, E Badet and G Becque. 1994. Vigilance et qualité de sommeil des soignants de nuit. Revue de l’infirmière 17:37-48.

Ernst, E and V Fialka. 1994. Idiopathic low back pain: Present impact, future directions. European Journal of Physical Medicine and Rehabilitation 4:69-72.

Escribà Agüir, V. 1992. Nurses’ attitudes towards shiftwork and quality of life, Scand J Soc Med 20(2):115-118.

Escribà Agüir V, S Pérez, F Bolumar, and F Lert. 1992. Retentissement des horaires de travail sur le sommeil des infirmiers. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Estryn-Béhar, M. 1990. Les groupes de parole: Une stratégie d’amélioration des relations avec les malades. Le concours médical 112(8):713-717.

—. 1991. Guide des risques professionnels du personnel des services de soins. Paris: Editions Lamarre.

Estryn-Béhar, M and N Bonnet. 1992. Le travail de nuit à l’hôpital. Quelques constats à mieux prendre en compte. Arch Mal Prof 54(8):709-719.

Estryn-Béhar, M and F Fonchain. 1986. Les troubles du sommeil du personnel hospitalier effectuant un travail de nuit en continu. Arch Mal Prof 47(3):167-172;47(4):241.

Estryn-Béhar, M and JP Fouillot. 1990a. Etude de la charge physique du personnel soignant, Documents pour le médecin du travail. INRS: 27-33.

—. 1990b. Etude de la charge mentale et approche de la charge psychique du personnel soignant. Analyse du travail des infirmières et aides-soignantes dans 10 services de soins. Documents pour le médecin du travail INRS 42:131-144.

Estryn-Béhar, M and C Hakim-Serfaty. 1990. Organisation de l’espace hospitalier. Techn hosp 542:55-63.

Estryn-Béhar, M and G Milanini. 1992. Concevoir les espaces de travail en services de soins. Technique Hospitalière 557:23-27.

Estryn-Béhar, M and H Poinsignon. 1989. Travailler à l’hopital. Paris: Berger Levrault.

Estryn-Béhar, M, C Gadbois, and E Vaichere. 1978. Effets du travail de nuit en équipes fixes sur une population féminine. Résultats d’une enquête dans le secteur hospitalier. Arch Mal Prof 39(9):531-535.

Estryn-Béhar, M, C Gadbois, E Peigné, A Masson, and V Le Gall. 1989b. Impact of nightshifts on male and female hospital staff, in Shiftwork: Health and Performance, edited by G Costa, G Cesana, K Kogi, and A Wedderburn. Proceedings of the International Symposium on Night and Shift Work. Frankfurt: Peter Lang.

Estryn-Béhar, M, M Kaminski, and E Peigné. 1990. Strenuous working conditions and musculoskeletal disorders among female hospital workers. Int Arch Occup Environ Health 62:47-57.

Estryn-Béhar, M, M Kaminski, M Franc, S Fermand, and F Gerstle F. 1978. Grossesse er conditions de travail en milieu hospitalier. Revue franç gynec 73(10) 625-631.

Estryn-Béhar, M, M Kaminski, E Peigné, N Bonnet, E Vaichère, C Gozlan, S Azoulay, and M Giorgi. 1990. Stress at work and mental health status. Br J Ind Med 47:20-28.

Estryn-Béhar, M, B Kapitaniak, MC Paoli, E Peigné, and A Masson. 1992. Aptitude for physical exercise in a population of female hospital workers. Int Arch Occup Environ Health 64:131-139.

Estryn Béhar, M, G Milanini, T Bitot, M Baudet, and MC Rostaing. 1994. La sectorisation des soins: Une organisation, un espace. Gestion hospitalière 338:552-569.

Estryn-Béhar, M, G Milanini, MM Cantel, P Poirier, P Abriou, and the ICU’s study group. 1995a. Interest of participative ergonomic methodology to improve an intensive care unit. In Occupational Health for Health Care Workers, 2nd edition, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

—. 1995b. Participative ergonomic methodology for the new fitting out of a cardiologic intensive care unit. In Occupational Health for Health Care Workers, 2nd edition, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Estryn-Béhar, M, E Peigné, A Masson, C Girier-Desportes, JJ Guay, D Saurel, JC Pichenot, and J Cavaré. 1989a. Les femmes travaillant à l’hôpital aux différents horaires, qui sont-elles? Que décrivent-elles comme conditions de travail? Que souhaitent-elles? Arch Mal Prof 50(6):622-628.

Falk, SA and NF Woods. 1973. Hospital noise-levels and potential health hazards, New England J Med 289:774-781.

Fanger, PO. 1973. Assessment of man’s thermal comfort in practice. Br J Ind Med 30:313-324.

—. 1992. Sensory characterization of air quality and pollution sources. In Chemical, Microbiological, Health and Comfort Aspects of Indoor Air Quality—State of the Art in SBS, edited by H Knoppel and P Wolkoff. Dordrecht, NL: Kluwer Academic Publishers.

Favrot-Laurens. 1992. Advanced technologies and work organization of hospital teams. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

—. 1992. Sensory characterization of air quality and pollution sources. In Chemical, Microbiological, Health and Comfort Aspects of Indoor Air Quality—State of the Art in Sick Building Syndrome, edited by H Koppel and P Wolkoff. Brussels and Luxembourg: EEC.

Ferstandig, LL. 1978. Trace concentrations of anesthetic gases: A critical review of their disease potential. Anesth Analg 57:328-345.

Finley, GA and AJ Cohen. 1991. Percieved urgency and the anaesthetist: Responses to common operating room monitor alarms. Can J Anaesth 38(8):958-964

Ford, CV and DK Wentz. 1984. The internship year: A study of sleep, mood states, and psychophysiologic parameters. South Med J 77:1435-1442.

Friedman, RC, DS Kornfeld, and TJ Bigger. 1971. Psychological problems associated with sleep deprivation in interns. Journal of Medical Education 48:436-441.

Friele, RD and JJ Knibbe. 1993. Monitoring the barriers with the use of patient lifts in home care as perceived by nursing personnel. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. LandsbergLech: Ecomed Verlag.

Gadbois, CH. 1981. Aides-soignantes et infirmières de nuit. In Conditions de travail et vie quotidienne. Montrougs: Agence Nationale pour l’Amélioration des Conditions de Travail.

Gadbois, C, P Bourgeois, MM Goeh-Akue-Gad, J Guillaume, and MA Urbain. 1992. Contraintes temporelles et structure de l’espace dans le processus de travail des équipes de soins. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Games, WP, and W Tatton-Braen. 1987. Hospitals Design and Development. London: Architectural Press.

Gardner, ER and RC Hall. 1981. The professional stress syndrome. Psychosomatics 22:672-680.

Gaube, J, H Feucht, R Laufs, D Polywka, E Fingscheidt, and HE Müller. 1993. Hepatitis A, B und C als desmoterische Infecktionen. Gessundheitwesen und Desinfextion 55:246-249.

Gerberding, JL. N.d. Open trial of Zidovudine Postexposure-chemoprophylaxis in Health Care Workers with Occupational Exposures to Human Immunodeficiency Virus. Skript SFGH.

—. 1995. Management of occupational exposures to blood-borne viruses. New Engl J Med 332:444-451.

Ginesta, J. 1989. Gases anestésicos. In Riesgos del Trabajo del Personal Sanitario, edited by JJ Gestal. Madrid: Editorial Interamericana McGraw-Hill.

Gold, DR, S Rogacz, N Bock, TD Tosteson, TM Baum, FE Speizer, and CA Czeiler. 1992. Rotating shift work, sleep and accidents related to sleepiness in hospital nurses. Am J Public Health 82(7):1011-1014.

Goldman, LI, MT McDonough, and GP Rosemond. 1972. Stresses affecting surgical performance and learning: Correlation of heart rate, electrocardiogram, and operation simultaneously recorded on videotapes. J Surg Res 12:83-86.

Graham, C, C Hawkins, and W Blau. 1983. Innovative social work practice in health care: Stress management. In Social Work in a Turbulent World, edited by M Dinerman. Washington, DC: National Association of Social Workers.

Green, A. 1992. How nurses can ensure the sounds patients hear have a positive rather than negative effect upon recovery and quality of life. Intensive & Critical Care Nursing Journal 8(4):245-248.

Griffin, WV. 1995. Social worker and agency safety. In Encyclopaedia of Social Work, 19th edition. Washington, DC: National Association of Social Workers.

Grob, PJ. 1987. Cluster of hepatitis B transmission by a physician. Lancet 339:1218-1220.

Guardino, X and MG Rosell. 1985. Exposicion laboral a gases anestésicos. In Notas Técnicas de Prevención. No. 141. Barcelona: INSHT.

—. 1992. Exposure at work to anesthetic gases. A controlled risk? Janus 12:8-10.

—. 1995. Exposure monitoring to anesthetic gases. In Occupational Health for Health Care Workers, edited by M Hagburg, F Hoffmann, U Stössel, and G Westlander. Solna: National Institute of Occupational Health.

Hagberg, M, F Hofmann, U Stössel, and G Westlander (eds.). 1993. Occupational Health for Health Care Workers. Landsberg/Lech: Ecomed Verlag.

Hagberg, M, F Hofmann, U Stössel, and G Westlander (eds.). 1995. Occupational Health for Health Care Workers. Singapore: International Commission on Occupational Health.

Haigh, R. 1992. The application of ergonomics to the design of workplace in health care buildings in the U.K. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Halm, MA and MA Alpen, 1993. The impact of technology on patient and families. Nursing Clinics of North America 28(2):443-457.

Harber, P, L Pena, and P Hsu. 1994. Personal history, training, and worksite as predictors of back pain of nurses. Am J Ind Med 25:519-526.

Hasselhorn, HM. 1994. Antiretrovirale prophylaxe nach kontakt mit HIV-jontaminierten. In Flüssigkeiten in Infektiologie, edited by F Hofmann. Landsberg/Lech: Ecomed Verlag.

Hasselhorn, HM and E Seidler.1993. Terminal care in Sweden—New aspects of the professional care of dying. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel U, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Heptonstall, J, K Porter, and N Gill. 1993. Occupational Transmission of HIV: Summary of Published Reports. London: Communicable Disease Surveillance Centre AIDS Centre.

Hesse, A, Lacher A, HU Koch, J Kublosch, V Ghane, and KF Peters. 1996. Update on the latex allergy topic. Hauzarzt 47(11):817-824.

Ho, DD, T Moudgil, and M Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. New Engl J Med 321:1621-1625.

Hodge, B and JF Thompson. 1990. Noise pollution in the operating theatre. Lancet 335:891-894.

Hofmann, F and H Berthold. 1989. Zur Hepatitis-B-Gefährdung des Krankenhauspersonals-Möglichkeiten der prae-und postexpositionellen Prophylaxe. Medizinische Welt 40:1294-1301.

Hofmann, F and U Stössel. 1995. Environmental health in the health care professions: Biological, physical, psychic, and social health hazards. Reviews on Environmental Health 11:41-55.

Hofmann, F, H Berthold, and G Wehrle. 1992. Immunity to hepatitis A in hospital personnel. Eur J Clin Microbiol Infect Dis 11(12):1195.

Hofmann, F, U Stössel, and J Klima. 1994. Low back pain in nurses (I). European Journal of Physical and Medical Rehabilitation 4:94-99.

Hofmann, F, B Sydow, and M Michaelis. 1994a. Mumps—berufliche Gefährdung und Aspekte der epidemiologischen Entwicklung. Gessundheitwesen und Desinfextion 56:453-455.

—. 1994b. Zur epidemiologischen Bedeutung der Varizellen. Gessundheitwesen und Desinfextion 56:599-601.

Hofmann, F, G Wehrle, K Berthold, and D Köster. 1992. Hepatitis A as an occupational hazard. Vaccine 10 suppl 1:82-84.

Hofmann, F, U Stössel, M Michaelis, and A Siegel. 1993. Tuberculosis—Occupational risk for health care workers? In Occupational Health for Health Care Workers, edited by M Hagberg. Landsberg/Lech: Ecomed Verlag.

Hofmann, F, M Michaelis, A Siegel, and U Stössel. 1994. Wirbelsäulenerkrankungen im Pflegeberuf. Medizinische Grundlagen und Prävention. Landsberg/Lech: Ecomed Verlag.

Hofmann, F, M Michaelis, M Nübling, and FW Tiller. 1995. European Hepatitis—A Study. Publikation in Vorereitung.

Hofmann, H and C Kunz. 1990. Low risk of health care workers for infection with hepatitis-C virus. Infection 18:286-288.

Holbrook, TL, K Grazier, JL Kelsey, and RN Stauffer. 1984. The Frequency of Occurrence, Impact, and Cost of Selected Musculoskeletal Conditions in the United States. Park Ridge, Il: American Academy of Orthopedic Surgeons.

Hollinger, FB. 1990. Hepatitis B virus. In Virology, edited by BN Fiedles and DM Knipe. New York: Raven Press.

Hopps, J and P Collins. 1995. Social work profession overview. In Encyclopedia of Social Work, 19th edition. Washington, DC: National Association of Social Workers.

Hubacova, L, I Borsky, and F Strelka. 1992. Work physiology problems of nurses working in inpatients departments. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Hunt, LW, AF Fransway, CE Reed, LK Miller, RT Jones, MC Swanson, and JW Yunginger. 1995. An epidemic of occupational allergy to latex involving health care workers. J Occup Environ Med 37(10):1204-1209.

Jacobson, SF and HK MacGrath. 1983. Nurses under Stress. New York: John Wiley & Sons.

Jacques, CHM, MS Lynch and JS Samkoff. 1990. The effects of sleep loss on cognitive performance of resident physicians. J Fam Pract 30:223-229.

Jagger, J, EH Hunt, J Brand-Elnagger, and RD Pearson. 1988. Rates of needle-stick injury caused by various devices in a university hospital. New Engl J Med 319:284-288.

Johnson, JA, RM Buchan, and J S Reif. 1987. Effect of waste anesthetic gas and vapor exposure on reproductive outcome in veterinary personnel. Am Ind Hyg Assoc J 48(1):62-66.

Jonasson, G, JO Holm, and J Leegard. Rubber allergy: An increasing health problem? Tuidsskr Nor Laegeforen 113(11):1366-1367.

Kandolin, I. 1993. Burnout of female and male nurses in shiftwork. Ergonomics 36(1/3):141-147.

Kaplan, RM and RA Deyo. 1988. Back pain in health care workers. In Back Pain in Workers, edited by RA Deyo. Philadelphia, PA: Hanley & Belfus.

Katz, R. 1983. Causes of death among nurses. Occup Med 45:760-762.

Kempe, P, M Sauter and I Lindner. 1992. Special characteristics of nurses for the aged who made use of a training program aimed to reduce burn-out symptoms and first results on treatment outcome. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Kerr, JH. 1985. Warning devices. Br J Anaesth 57:696-708.

Kestin, IG, RB Miller, and CJ Lockhart. 1988. Auditory alarms during anesthesia monitoring. Anesthesiology 69(1):106-109.

Kinloch-de-los, S, BJ Hirschel, B Hoen, DA Cooper, B Tindall, A Carr, H Sauret, N Clumeck, A Lazzarin, and E Mathiesen. 1995. A controlled trial of Zidovudine in primary human immunodeficiency virus infection. New Engl J Med 333:408-413.

Kivimäki, M and K Lindström. 1995. The crucial role of the head nurse in a hospital ward. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Klaber Moffet, JA, SM Chase, I Portek, and JR Ennis. 1986. A controlled study to evaluate the efectiveness of the back pain school in the relief of chronic low back pain. Spine 11:120-122.

Kleczkowski, BM, C Montoya-Aguilar, and NO Nilsson. 1985. Approaches to Planning and Design of Health Care Facilities in Developing Areas. Vol. 5. Geneva: WHO.

Klein, BR and AJ Platt. 1989. Health Care Facility Planning and Construction. New York: Van Nostrand Reinhold.

Kelin, R, K Freemann, P Taylor, C Stevens. 1991. Occupational risk for hepatits C virus infection among New York City dentists. Lancet 338:1539-1542.

Kraus, H. 1970. Clinical Treatment of Back and Neck Pain. New York: McGraw-Hill.

Kujala, VM and KE Reilula. 1995. Glove-induced dermal and respiratory symptoms among health care workers in one Finnish hospital. Am J Ind Med 28(1):89-98.

Kurumatani, N, S Koda, S Nakagiri, K Sakai, Y Saito, H Aoyama, M Dejima, and T Moriyama. 1994. The effects of frequently rotating shiftwork on sleep and the family life of hospital nurses. Ergonomics 37:995-1007.

Lagerlöf, E and E Broberg. 1989. Occupational injuries and diseases. In Occupational Hazards in the Health Professions, edited by DK Brune and C Edling. Boca Raton, FL: CRC Press.

Lahaye, D, P Jacques, G Moens, and B Viaene. 1993. The registration of medical data obtained by preventive medical examinations on health care workers. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, F, U Stössel and G Westlander. Landsberg/Lech: Ecomed Verlag.

Lampher, BP, CC Linneman, CG Cannon, MM DeRonde, L Pendy, and LM Kerley. 1994. Hepatitis C virus infection in health care workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 15:745-750.

Landau, C, S Hall, SA Wartman, and MB Macko. 1986. Stress in social and family relationships during medical residency. Journal of Medical Education 61:654-660.

Landau, K. 1992. Psycho-physical strain and the burn-out phenomen amongst health care professionals. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Landewe, MBM and HT Schröer. 1993. Development of a new, integrated patient transfer training program—Primary prevention of low back pain. In Occupational Health for Health Care Workers, editeb by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Lange, M. 1931. Die Muskelhärten (Myogelosen). Munich: JF Lehman Verlag.

Lange, W and KN Masihi. 1986. Durchseuchung mit Hepatitis-A- und B-Virus bei medizinischem Personal. Bundesgesundheitsol 29;183-87.

Lee, KA. 1992. Self-reported sleep disturbances in employed women. Sleep15(6):493-498.

Lempereur, JJ. 1992. Prévention des dorso-lombalgies. Influence du vêtement de travail sur le comportement gestuel. Spécifications ergonomiques. Cah Kinésither 156,:4.

Leppanen, RA and MA Olkinuora. 1987. Psychological stress experienced by health care personnel. Scand J Work Environ Health 13:1-8.

Lert, F, MJ Marne, and A Gueguen. 1993. Evolution des conditions de travail des infirmières des hôpitaux publics de 1980 à 1990. Revue de l’Epidémiologie et de santé publique 41:16-29.

Leslie, PJ, JA Williams, C McKenna, G Smith and RC Heading. 1990. Hours, volume, and type of work of preregistration house officers. Brit Med J 300:1038-1041.

Lettau, LA, HJ Alfred, RH Glew, HA Fields, MJ Alter, R Meyer, SC Hadler, and JE Maynard. 1986. Nosocomial transmission of delta hepatitis. Ann Intern Med 104:631-635.

Levin, H. 1992. Healthy buildings—Where do we stand, where do we go? In Chemical, Microbiological, Health and Comfort Aspects of Indoor Air Quality: State of the Art in Sick Building Syndrome, edited by H Knoppel and P Wolkoff. Brussels and Luxembourg: EEC.

Lewittes, LR and VW Marshall. 1989. Fatigue and concerns about quality of care among Ontario interns and residents. Can Med Assoc J 140:21-24.

Lewy, R. 1990. Employees at Risk: Protection and Health of Health Care Workers. New York: Van Nostrand Reinhold.

Lindström, A and M Zachrisson. 1973. Ryggbesvär och arbetssoförmaga Ryyggskolan. Ett Försok till mer rationeli fysikalist terapi. Socialmet T 7:419-422.

Lippert. 1971. Travel in nursing units. Human Factors 13(3):269-282.

Ljungberg, AS, A Kilbom, and MH Goran. 1989. Occupational lifting by nursing aides and warehouse workers. Ergonomics 32:59-78.

Llewelyn-Davies, R and J Wecks. 1979. In-patient areas. In Approaches to Planning and Design of Health Care Facilities in Developing Areas, edited by BM Kleczkowski and R Piboleau. Geneva: WHO.

Loeb, RG, BR Jones, KH Behrman, and RJ Leonard. 1990. Anesthetists cannot identify audible alarms. Anesthesiology 73(3A):538.

Lotas, MJ. 1992. Effects of light and sound in the neonatal intensive care unit environment on the low-birth-weight infant. NAACOGS Clinical Issues in Perinatal & Womens Health Nursing 3(1):34-44.

Lurie, HE, B Rank, C Parenti, T Wooley, and W Snoke. 1989. How do house officers spend their nights? A time study of internal medicine house staff on call. New Engl J Med 320:1673-1677.

Luttman, A, M Jäger, J Sökeland, and W Laurig. 1996. Electromyographical study on surgeons in urology II. Determination of muscular fatigue. Ergonomics 39(2):298-313.

Makino, S. 1995. Health problems in health care workers in Japan. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsbeg/Lech: Ecomed Verlag.

Malchaire, JB. 1992. Analysis of the work load of nurses. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Manuaba, A. 1992. Social-cultural approach is a must in designing hospital in developing countries, Indonesia as a case study. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Maruna, H. 1990. Zur Hepatitis-B-Durchseuchung in den Berufen des Gesundheits und Fürsorgewesens der Republik Österreichs, Arbeitsmed. Präventivmed. Sozialmed 25:71-75.

Matsuda, A. 1992. Ergonomics approach to nursing care in Japan. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

McCall, T. 1988. The impact of long working hours on resident physicians. New Engl J Med 318(12):775-778.

McCloy, E. 1994. Hepatitis and the EEC Directive. Presented at the 2nd International Conference on Occupational Health for Health Care Workers, Stockholm.

McCormick, RD, MG Meuch, IG Irunk, and DG Maki. 1991. Epidemiology for hospital sharp injuries: A 14-year prospective study in the pre-AIDS and AIDS era. Am J Med 3B:3015-3075.

McCue, JD. 1982. The effects of stresses on physicians and their medical practice. New Engl J Med 306:458-463.

McIntyre, JWR. 1985. Ergonomics: Anaesthetists’ use of auditory alarms in the operating room. Int J Clin Monit Comput 2:47-55

McKinney, PW, MM Horowitz, and RJ Baxtiola. 1989. Susceptibility of hospital-based health care personnel to varicella zoster virus infection. Am J Infect Control 18:26-30.

Melleby, A. 1988. Exercise program for a healthy back. In Diagnosis and Treatment of Muscle Pain. Chicago, IL: Quintessence Books.

Meyer,TJ, SE Eveloff, MS Bauer, WA Schwartz, NS Hill, and PR Millman. 1994. Adverse environmental conditions in the respiratory and medical intensive care unit settings. Chest 105:1211-1216.

Miller, E, J Vurdien, and P Farrington. 1993. Shift age in chickenpox. Lancet 1:341.

Miller, JM. 1982. William Stewart Halsted and the use of the surgical rubber glove. Surgery 92:541-543.

Mitsui, T, K Iwano, K Maskuko, C Yanazaki, H Okamoto, F Tsuda, T Tanaka, and S Mishiros. 1992. Hepatitis C virus infection in medical personnel after needlestick accidents. Hepatology 16:1109-1114.

Modig, B. 1992. Hospital ergonomics in a biopsychosocial perspective. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Momtahan, K, R Hétu, and B Tansley. 1993. Audibility and identification of auditory alarms in the operating room and intensive care unit. Ergonomics 36(10):1159-1176.

Momtahan, KL and BW Tansley. 1989. An ergonomic analysis of the auditory alarm signals in the operating room and recovery room. Presented at the Annual Meeting of the Canadian Acoustical Association, 18 October, Halifax, NS.

Montoliu, MA, V Gonzalez, B Rodriguez, JF Quintana, and L Palenciano.1992. Conditions de travail dans la blanchisserie centrale des grands hôpitaux de Madrid. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Moore, RM, YM Davis, and RG Kaczmarek. 1993. An overview of occupational hazards among veterinarians, with particular reference to pregnant women. Am J Ind Hyg Assoc 54(3):113-120.

Morel, O. 1994. Les agents des services hospitaliers. Vécu et santé au travail. Arch mal prof 54(7):499-508.

Nachemson, AL and GBJ Anderson. 1982. Classification of low back pain. Scand J Work Environ Health 8:134-136.

National Health Service (NHS). 1991a. Design Guide. The Design of Community Hospitals. London: Her Majesty’s Stationery Office.

—. 1991b. Health Building Note 46: General Medical Practice Premises for the Provision of Primary Health Care Service. London: Her Majesty’s Stationery Office.

National Institute for Occupational Safety and Health (NIOSH). 1975. Development and Evaluation of Methods for the Elimination of Waste Anesthetic Gases and Vapors in Hospitals. DHEW (NIOSH) Publication No. 75-137. Cincinnati, OH: NIOSH.

—. 1997a. Control of Occupational Exposure to N2O in the Dentral Operatory. DHEW (NIOSH) Publication No. 77-171. Cincinnati, OH: NIOSH.

—. 1977b. Criteria for a Recommended Standard: Occupational Exposure to Waste Anesthetic Gases and Vapors. DHEW (NIOSH) Publication No. 77-1409. Cincinnati, OH: NIOSH.

—. 1988. Guidelines for Protecting the Safety and Health of Health Care Workers. DHHS (NIOSH) Publication No. 88-119. Cincinnati, OH: NIOSH.

—. 1994. NIOSH Alert: Request for Assistance in Controlling Exposures to Nitrous Oxide during Anesthetic Administration. DHHS (NIOSH) Publication No. 94-100. Cincinnati, OH: NIOSH.

Niu, MT, DS Stein, and SM Schnittmann. 1993. Primary human immunodeficiency virus type 1 infection: Review of pathogenesis and early treatment interventions in human and animal retrovirus infections. J Infect Dis 168:1490-1501.

Noweir, MH and MS al-Jiffry. 1991. Study of noise pollution in Jeddah hospitals. Journal of the Egyptian Public Health Association 66 (3/4):291-303.

Nyman, I and A Knutsson. 1995. Psychosocial wellbeing and sleep quality in hospital night and day workers. In Occuaptional Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Objectif Prévention No spécial. 1994. Le lève personne sur rail au plafond: Outil de travail indispensable. Objectif Prévention 17(2):13-39.

O’Carroll, TM. 1986. Survey of alarms in an intensive therapy unit. Anaesthesia 41:742-744.

Occupational Safety and Health Administration (OSHA). 1991. Occupational Exposure to Bloodborne Pathogens: Final Rule. 29 CFR Part 1910.1030. Washington, DC: OSHA.

Oëler, JM. 1993. Developmental care of low birth weight infants. Nursing Clinics of North America 28(2):289-301.

Öhling, P and B Estlund. 1995. Working technique for health care workers. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander G. Landsberg/Lech: Ecomed Verlag.

Ollagnier, E and Lamarche MJ. 1993. Une intervention ergonomique dans un hôpital suisse: Impact sur la santé de l’organisation du personnel et des patients. In Ergonomie et santé, edited by D Ramaciotti and A Bousquet. Actes du XXVIIIe congrès de la SELF. Geneva: SELF.

Ott, C, M Estryn-Béhar, C Blanpain, A Astier, and G Hazebroucq. 1991. Conditionnement du médicament et erreurs de médication. J Pharm Clin 10:61-66.

Patkin, M. 1992. Hospital architecture: An ergonomic debacle. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Payer, L. 1988. Medicine and Culture: The Variety of Treatment in the United States, England, West Germany and France. New York: H. Holt.

Payne, R and J Firth-Cozens (eds.). 1987. Stress in Health Professions. New York: John Wiley & Sons.

—. 1995. Determination of dinitrogen oxide (N2O) in urine as control to anesthetic exposure. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hoffmann, U Stössel, and G Westlander. Solna: National Institute of Occupational Health.

Pelikan, JM. 1993. Improving occupational health for health care workers within the health promoting hospital: Experiences from the Vienna WHO model project “health and hospital”. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Pérez, L, R De Andrés, K. Fitch, and R Najera. 1994. Seroconversiones a VIH tras Sanitarios en Europa. Presented at the 2nd Reunión Nacional sobre el SIDA Cáceres.

Philip, RN, KRT Reinhard, and DB Lackman. 1959. Observations on a mumps epidemic in a “virgin” population. Am J Hyg 69:91-111.

Pottier, M. 1992. Ergonomie à l’hôpital-hospital ergonomics. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Poulton, EC, GM Hunt, A Carpenter, and RS Edwards. 1978. The performance of junior hospital doctors following reduced sleep and long hours of work. Ergonomics 21:279-295.

Pöyhönen, T and M Jokinen. 1980. Stress and Other Occupational Health Problems Affecting Hospital Nurses. Vantaa, Finland: Tutkimuksia.

Raffray, M. 1994. Etude de la charge physique des AS par mesure de la fréquence cardiaque. Objectif soins 26:55-58.

Ramaciotti, D, S Blaire, A Bousquet, E Conne, V Gonik, E Ollagnier, C Zummermann, and L Zoganas. 1990. Processus de régulation des contraintes économiques physiologiques et sociales pour différents groupes de travail en horaires irréguliers et de nuit. Le travail humain 53(3):193-212.

Reuben, DB. 1985. Depressive symptoms in medical house officers: Effects of level of training and work rotation. Arch Intern Med 145:286-288.

Reznick, RK and JR Folse. 1987. Effect of sleep deprivation on the performance of surgical residents. Am J Surg 154:520-52.

Rhoads, JM.1977. Overwork. JAMA 237:2615-2618.

Rodary, C and A Gauvain-Piquard 1993. Stress et épuisement professionnel. Objectif soins 16:26-34.

Roquelaure, Y, A Pottier, and M Pottier. 1992. Approche ergonomique comparative de deux enregistreurs electroencéphalographiques. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Rosell, MG, P Luna, and X Guardino. 1989. Evaluacion y Control de Contaminantes QuPmicos en Hospitales. Technical Document No. 57. Barcelona: INSHT.

Rubin, R, P Orris, SL Lau, DO Hryhorczuk, S Furner, and R Letz. 1991. Neurobehavioral effects of the on-call experience in housestaff physicians. J Occup Med 33:13-18.

Saint-Arnaud, L, S Gingras, R Boulard., M Vezina and H Lee-Gosselin. 1992. Les symptômes psychologiques en milieu hospitalier. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Samkoff, JS, CHM Jacques. 1991. A review of studies concerning effects of sleep deprivation and fatigue on residents’ performance. Acad Med 66:687-693.

Sartori, M, G La Terra, M Aglietta, A Manzin, C Navino, and G Verzetti. 1993. Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 25:270-271.

Saurel, D. 1993. CHSCT Central, Enquete “Rachialgies” Résultats. Paris: Assistance Publique-Höpitaux de Paris, Direction du personnel et des relations sociales.

Saurel-Cubizolles, MJ, M Hay, and M Estryn-Béhar. 1994. Work in operating rooms and pregnancy outcome among nurses. Int Arch Occup Environ Health 66:235-241.

Saurel-Cubizolles, MJ, MKaminski, J Llhado-Arkhipoff, C Du Mazaubrum, M Estryn-Behar, C Berthier, M Mouchet, and C Kelfa. 1985. Pregnancy and its outcome among hospital personnel according to occupation and working condition. Journal of Epidemiology and Community Health 39:129-134.

Schröer, CAP, L De Witte, and H Philipsen. 1993. Effects of shift work on quality of sleep, health complaints and medical consumption of female nurses. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Senevirane, SR, De A and DN Fernando. 1994. Influence of work on pregnancy outcome. Int J Gynecol Obstet VOL: 35-40.

Shapiro, ET, H Pinsker and JH Shale. 1975. The mentally ill physician as practitioner. JAMA 232(7):725-727.

Shapiro, RA and T Berland. 1972. Noise in the operating room. New Engl J Med 287(24):1236-1238.

Shindo, E. 1992. The present condition of nursing ergonomics in Japan. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Siegel, A, M Michaelis, F Hofmann, U Stössel, and W Peinecke. 1993. Use and acceptance of lifting aids in hospitals and geriatric homes. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Smith, MJ, MJ Colligan, IJ Frocki, and DL Tasto. 1979. Occupational injury rates among nurses as a function of shift schedule. Journal of Safety Research 11(4):181-187.

Smith-Coggins, R, MR Rosekind, S Hurd, and KR Buccino. 1994. Relationship of day versus night sleep to physician performance and mood. Ann Emerg Med 24:928-934.

Snook, SH. 1988a. Approaches to the control of back pain in industry. In Back Pain in Workers, edited by RA Deyo. Philadelphia: Hanley & Belfus.

—. 1988b. The costs of back pain in industry. In Back Pain in Workers, edited by RA Deyo. Philadelphia: Hanley & Belfus.

South, MA, JL Sever, and L Teratogen. 1985. Update: The congenital rubella syndrome. Teratology 31:297-392.

Spence, AA. 1987. Environmental pollution by inhalation anaesthetics. Br J Anaesth 59:96-103.

Stellman, JM. 1976. Women’s Work, Women’s Health: Myths and Realities. New York: Pantheon.

Steppacher, RC and JS Mausner. 1974. Suicide in male and female physicians. JAMA 228(3):323-328.

Sterling, DA. 1994. Overview of health and safety in the health care environment. In Essentials of Modern Hospital Safety, edited by W Charney. Boca Raton, FL: Lewis Publishers.

Stoklov, M, P Trouiller, P Stieglitz, Y Lamalle, F Vincent, A Perdrix, C Marka, R de Gaudemaris, JM Mallion, and J Faure. 1983. L’exposition aux gaz anethésiques: Risques et prévention. Sem Hôs 58(29/39):2081-2087.

Storer, JS, HH Floyd, WL Gill, CW Giusti, and H Ginsberg. 1989. Effects of sleep deprivation on cognitive ability and skills of pediatrics residents. Acad Med 64:29-32.

Stubbs, DA, PW Buckle, and PM Hudson. 1983. Back pain in the nursing profession; I Epidemiology and pilot methodology. Ergonomics 26:755-765.

Sundström-Frisk C and M Hellström.1995. The risk of making treatment errors, an occupational stressor. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Swann-D’Emilia, B, JCH Chu, and J Daywalt. 1990. Misadministration of prescribed radiation dose. Medical Dosimetry 15:185-191.

Sydow, B and F Hofmann. 1994. Unpublished results.

Tannenbaum, TN and RJ Goldberg. 1985. Exposure to anaesthetic gases and reproductive outcome: A review of epidemiologic literature. J Occup Med 27:659-671.

Teyssier-Cotte, C, M Rocher, and P Mereau. 1987. Les lits dans les établissements de soins. Documents pour le médecin du travail. INRS 29:27-34.

Theorell, T. 1989. The psychosocial working environment. In Occupational Hazards in the Health Professions, edited by DK Brune and C Edling. Boca Raton, FL: CRC Press.

Theorell T. 1993. On the psychosocial environment in care. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech : Ecomed Verlag.

Tintori, R and M Estryn-Béhar. 1994. Communication: Où, quand, comment? Critères ergonomiques pour améliorer la communication dans les services de soins. Gestions Hospitalières 338:553-561.

Tintori, R, M Estryn-Behar, J De Fremont, T Besse, P Jacquenot, A Le Vot, and B Kapitaniak. 1994. Evaluation des lits à hauteur variable. Une démarche de recherche en soins infirmiers. Gestions Hospitalières 332:31-37.

Tokars, JI, R Marcus, DH Culver, CA Schable, PS McKibben, CL Bandea, and DM Bell. 1993. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 118:913-919.

Toomingas, A. 1993. The health situation among Swedish health care workers. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Topf, M. 1992. Effects of personal control over hospital noise on sleep. Research in Nursing & Health 15(1):19-28.

Tornquist, A and P Ullmark. 1992. Corporate Space and Architecture, Actors and Procedures. Paris: Ministère de l’équipement du logement et des transports.

Townsend, M. 1994. Just a glove? Br J Theatre Nurs 4(5):7,9-10.

Tran, N, J Elias, T Rosenber, D Wylie, D Gaborieau, and A Yassi. 1994. Evaluation of waste anesthetic gases, monitoring strategies and corelations between nitrous oxide levels and health symptoms. Am Ind Hyg Assoc J 55(1):36-42.

Turner, AG, CH King, and G Craddock. 1975. Measuring and reducing noise. Noise profile of hospital shows that even “quiet” areas are too noisy. Hospital JAHA 49:85-89.

US Preventive Services Task Force. 1989. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 interventions. Baltimore: Williams & Wilkins.

Vaillant, GE, NC Sorbowale, and C McArthur. 1972. Some psychologic vulnerabilities of physicians. New Engl J Med 287:372-375.

Vaisman, AI. 1967. Working conditions in surgery and their effects on the health of anesthesiologists. Eskp Khir Anesteziol 12:44-49.

Valentino, M, MA Pizzichini, F Monaco, and M Governa. 1994. Latex-induced asthma in four healthcare workers in a regional hospital. Occup Med (Oxf) 44(3):161-164.

Valko, RJ and PJ Clayton. 1975. Depression in the internships. Dis Nerv Syst 36:26-29.

Van Damme, P and GA Tormanns. 1993. European risk model. In Proceedings of the European Conference on Hepatitis B as an Occupatioonal Hazard. 10-12.

Van Damme, P, R Vranckx, A Safary, FE Andre, and A Mehevs. 1989. Protective efficacy of a recombinant deoxyribonucleic acid hepatitis B vaccine in institutionalized mentally handicapped clients. Am J Med 87(3A):265-295.

Van der Star, A and M Voogd. 1992. User participation in the design and evaluation of a new model hospital bed. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Van Deursen, CGL, CAM Mul, PGW Smulders and CR De Winter. 1993. Health and working situation of day nurses compared with a matched group of nurses on rotating shift work. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Van Hogdalem, H. 1990. Design guidelines for architects and users. In Building for People in Hospitals, Workers and Consumers. Luxembourg: European Foundation for the Improvement of Living and Working Conditions.

Van Wagoner, R and N Maguire. 1977. A study of hearing loss among employees in a large urban hospital. Canadian Journal of Public Health 68:511-512.

Verhaegen, P, R Cober, DE Smedt, J Dirkx, J Kerstens, D Ryvers, and P Van Daele. 1987. The adaptation of night nurses to different work schedules. Ergonomics 30(9):1301-1309.

Villeneuve, J. 1992. Une demarche d’ergonomie participative dans le secteur hôspitalier. In Ergonomie à l’hôpital (Hospital ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

—. 1994. PARC: Des fondations solides pour un projet de rénovation ou de construction Objectif prévention (Montreal) 17(5):14-16.

Wade, JG and WC Stevens. 1981. Isoflurane: An ansaesthetic for the eighties? Anesth Analg 60(9):666-682.

Wahlen, L. 1992. Noise in the intensive care setting. Canadian Critical Care Nursing Journal, 8/9(4/1):9-10.

Walz, T, G Askerooth, and M Lynch. 1983. The new upside-down welfare state. In Social Work in a Turbulent World, edited by M Dinerman. Washington, DC: National Association of Social Workers.

Wands, SE and A Yassi. 1993. Modernization of a laundry processing plant: Is it really an improvement? Appl Ergon 24(6):387-396.

Weido, AJ and TC Sim. 1995. The burgeoning problem of latex sensitivity. Surgical gloves are only the beginning. Postgrad Med 98(3):173-174,179-182,184.

Wiesel, SW, HL Feffer, and RH Rothmann. 1985. Industrial Low Back Pain. Charlottesville,VA: Michie.

Wigaeus Hjelm, E, M Hagberg, and S Hellstrom. 1993. Prevention of musculoskeletal disorders in nursing aides by physical training. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Wigand, R and Y Grenner. 1988. Personaluntersuchungen auf Immunität gegen Masern, Varizellen und Röteln, Saarländ. Ärztebl 41:479-480.

Wilkinson, RT, PD Tyler and CA Varey. 1975. Duty hours of young hospital doctors: Effects on the quality of work. J Occup Psychol 48:219-229.

Willet, KM. 1991. Noise-induced hearing loss in orthopaedic staff. J Bone Joint Surg 73:113-115.

Williams, M and JD Murphy. 1991. Noise in critical care units: A quality assurance approach. Journal of Nursing Care Quality 6(1):53-59.

World Health Organization (WHO). 1990. Guidelines on AIDS and First Aid in the Workplace. WHO AIDS Series No. 7. Geneva: WHO.

—. 1991. Biosafety Guidelines for Diagnostic and Research Laboratories Working with HIV. WHO AIDS Series No. 9. Geneva: WHO.

—. 1995. Weekly Epidemiological Report (13 January).

Wugofski, L. 1995. Occupational accident in health care workers—Epidemiology and prevention. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Singapore: International Commission on Occupational Health.

Yassi, A. 1994. Assault and abuse of health care workers in a large teaching hospital. Can Med Assoc J 151(9):1273-1279.

Yassi, A and M McGill. 1991. Determinants of blood and body fluid exposure in a large teaching hospital: Hazards of the intermittent intravenous procedure. American Journal of Infection Control 19(3):129-135.

—. 1995. Efficacy and cost-effectiveness of a needleless intravenous access system. American Journal of Infection Control 22(2):57-64.

Yassi, A, J Gaborieau, J Elias, and D Willie. 1992. Identification and control of hazardous noise levels in a hospital complex. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Yassi, A, D Gaborieau, I Gi